<SEC-DOCUMENT>0001683168-23-004233.txt : 20230620
<SEC-HEADER>0001683168-23-004233.hdr.sgml : 20230620
<ACCEPTANCE-DATETIME>20230620075813
ACCESSION NUMBER:		0001683168-23-004233
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230615
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230620
DATE AS OF CHANGE:		20230620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PRECISION OPTICS CORPORATION, INC.
		CENTRAL INDEX KEY:			0000867840
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				042795294
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10647
		FILM NUMBER:		231023422

	BUSINESS ADDRESS:	
		STREET 1:		22 EAST BROADWAY
		CITY:			GARDNER
		STATE:			MA
		ZIP:			01440
		BUSINESS PHONE:		978-630-1800

	MAIL ADDRESS:	
		STREET 1:		22 EAST BROADWAY
		CITY:			GARDNER
		STATE:			MA
		ZIP:			01440

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRECISION OPTICS Corp INC
		DATE OF NAME CHANGE:	20111027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRECISION OPTICS CORPORATION INC
		DATE OF NAME CHANGE:	19930328

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRECISION OPTICS CORP INC
		DATE OF NAME CHANGE:	19600201
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>poci_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:POCI="http://poci.com/20230615">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_POCI_poci.com_20230615 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20230615_20230615 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0000867840 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityCentralIndexKey">0000867840</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="poci-20230615.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-06-15to2023-06-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000867840</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-15</xbrli:startDate>
        <xbrli:endDate>2023-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>FORM&#160;<span id="xdx_909_edei--DocumentType_c20230615__20230615_zDpFISj64acl"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)&#160;of
the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)
<span id="xdx_90B_edei--DocumentPeriodEndDate_c20230615__20230615_z9Ro5c7BZPga"> <ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 15, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityRegistrantName_c20230615__20230615_zSTU9xgizkEi" style="font-size: 12pt"><b><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityRegistrantName">PRECISION
OPTICS CORPORATION, INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20230615__20230615_zbQ57TkEYn5b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Massachusetts</ix:nonNumeric></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span id="xdx_901_edei--EntityFileNumber_c20230615__20230615_zZCkSpni1wNa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityFileNumber">001-10647</ix:nonNumeric></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20230615__20230615_z5bTh5ls84jd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityTaxIdentificationNumber">04-2795294</ix:nonNumeric></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">of incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">File Number)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Identification No.)</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 45%; text-align: center"><span id="xdx_908_edei--EntityAddressAddressLine1_c20230615__20230615_z5SzYbMFpE25" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressAddressLine1">22
    East Broadway</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br />
    <span id="xdx_909_edei--EntityAddressCityOrTown_c20230615__20230615_zSSBHvzczpEc"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressCityOrTown">Gardner</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
    <span id="xdx_900_edei--EntityAddressStateOrProvince_c20230615__20230615_z3ndr27MIvT6"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 45%; text-align: center"><span id="xdx_908_edei--EntityAddressPostalZipCode_c20230615__20230615_zAonygMpB9vc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressPostalZipCode">01440</ix:nonNumeric></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code) <span id="xdx_906_edei--CityAreaCode_c20230615__20230615_zpOHFMBI7Ftf"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:CityAreaCode">(978)</ix:nonNumeric></span> <span id="xdx_90F_edei--LocalPhoneNumber_c20230615__20230615_zhGm0oaCQzy9"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:LocalPhoneNumber">630-1800</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">N/A</p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration: underline">see</span>&#160;General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span id="xdx_901_edei--WrittenCommunications_c20230615__20230615_zhZa1yBd5cFk"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span id="xdx_901_edei--SolicitingMaterial_c20230615__20230615_zNhvNTNzYuh6"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-indent: -40.5pt"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20230615__20230615_ziplbiyATooe"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-indent: -40.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-indent: -40.5pt"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20230615__20230615_zIWKmGRq1579"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-indent: -40.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">Securities registered pursuant to
Section 12(b) of the Act: None</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">Securities registered pursuant to
Section 12(g) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 28%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Trading symbol(s)</span></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 37%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--Security12bTitle_c20230615__20230615_zKiTGf4eqwY3"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:Security12bTitle">Common stock, $0.01 par value</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_c20230615__20230615_zi9HPtZNNd6i"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:TradingSymbol">POCI</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_903_edei--SecurityExchangeName_c20230615__20230615_zvMvXsri4LW6"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2&#160;of the Securities Exchange
Act of 1934 (17 CFR&#160;&#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span id="xdx_901_edei--EntityEmergingGrowthCompany_c20230615__20230615_zXkGdmTPHLmg"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160; &#160; &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.02 Unregistered Sale of Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 15, 2023, we entered into agreements with
certain institutional and accredited investors calling for the purchase and sale of 420,000 shares of our common stock, $0.01 par value,
at a purchase price of $6.00 per share. The stock issuance is expected to close on June 20, 2023, at which time we expect to receive gross
proceeds of approximately $2.52 million before deducting placement agent commissions and other estimated offering expenses. A.G.P./Alliance
Global Partners is acting as the sole placement agent for this private placement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conjunction with the placement, we also entered
into a registration rights agreement with the investors, whereby we are obligated to file a registration statement with the Securities
Exchange Commission under the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;), by (subject to exceptions) the 20<sup>th</sup>
day after the June 20, 2023 closing date. We will incur certain penalties if the registration statement has not been filed by the applicable
deadline or if the registration statement has not been declared effective by the Commission by (subject to exceptions) the 75<sup>th</sup>
day after the applicable filing deadline.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offer and sale of these shares of common stock
are exempt from registration under the 1933 Act pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D, inasmuch as all of the
purchasers are accredited investors within the meaning of Rule 501(a) of Regulation D, no general solicitation or advertising of any kind
was used in connection with the offering, and the offering was made only to a limited number of offerees who each were believed to be
knowledgeable and sophisticated investors. Until registered, the shares so issued will be considered &#8220;restricted securities&#8221;
and thus generally may not be offered or sold by the holders in the absence of an exemption from securities registration requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The agreements with the investors contain a representation
from us to the effect that there have been no material adverse developments with respect to the Company since the date of filing of our
most recent report on Form 10-Q.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: center; width: 1.25in"><span style="text-decoration: underline">Exhibit No.</span></td>
  <td><span style="text-decoration: underline">Description</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: center; width: 1.25in; vertical-align: top">10.1</td><td><a href="poci_ex1001.htm">Form of Securities Purchase Agreement, by and among Precision Optics Corporation, Inc. and several investors, dated June 15, 2023</a>.</td></tr>
<tr style="vertical-align: top">
<td style="text-align: center; vertical-align: top">10.2</td><td><a href="poci_ex1002.htm">Form of Registration Rights Agreement, by and among Precision Optics Corporation, Inc. and several investors, dated June 15, 2023.</a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: center; vertical-align: top">10.3</td><td><a href="poci_ex1003.htm">Placement Agent Agreement, by and between Precision Optics Corporation, Inc. and A.G.P./Alliance Global Partners, dated June 15, 2023.</a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: center; vertical-align: top">99.1</td><td><a href="poci_ex9901.htm">Press release dated June 15, 2023 announcing private placement of common stock.</a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; white-space: nowrap; font-size: 10pt; vertical-align: top">104</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font-size: 10pt">PRECISION OPTICS CORPORATION, INC.</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 52%"><span style="font-size: 10pt">Date: June 20, 2023</span></td>
    <td style="width: 2%"><span style="font-size: 10pt">By:&#160;</span></td>
    <td style="vertical-align: top; width: 46%"><span style="font-size: 10pt"><i>/s/ Joseph N. Forkey</i></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="border-top: black 1pt solid; vertical-align: top"><span style="font-size: 10pt">Name: Joseph N. Forkey<br />
Title: President</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZiyYBXXRpURGrSBFxG+xUgm2mTNKqR/KWxhZxGBiG/9//QkzEhta2RobLssjhhE1bm4BQYIWM7orRkW13KcRb4M36wMaF4f2BGUUGIzOfKnmNwmDtrccyBaVncjHTCqRO1QKOe5F89YxcZUt0wZoajCvhyNSyxWD4NSaczJMcNa+h6ozsLbkYN5Wj/AYtlYYD9eZBfPeQ55lIJsMkYsPUtd+azgdqYFVjE7v8iP43+QAUrUlE -->



</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>poci_ex1001.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, BY AND AMONG PRECISION OPTICS CORPORATION, INC. AND SEVERAL INVESTORS, DATED JUNE 15, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of June 15, 2023, between Precision Optics Corporation, Inc., a Massachusetts corporation
(the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally
and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, contemporaneously
with the sale of the securities hereunder, the parties hereto will execute and deliver a Registration Rights Agreement, in the form attached
hereto as&nbsp;<U>Exhibit&nbsp;A</U>&nbsp;(the &ldquo;<U>Registration Rights Agreement</U>&rdquo;), pursuant to which the Company will
agree to provide certain registration rights in respect of the Shares (as hereinafter defined) under the Securities Act, and the rules
and regulations promulgated thereunder, and applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>. In
addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set
forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to
remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar
orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally are open for use by customers
on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s obligations
to deliver the Securities, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Verrill Dana LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Schedules</U>&rdquo;
means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight
(New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City
time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise
instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective Date</U>&rdquo;
means the earliest of the date that (a) the initial Registration Statement registering for resale all Shares has been declared effective
by the Commission, (b) all of the Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement
for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions,
(c) following the one year anniversary of the Closing Date provided that a holder of Shares is not an Affiliate of the Company, or (d)
all of the Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or
manner-of-sale restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or
option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members
of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities (including
options, rights or warrants) exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the
date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of
such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with
stock splits or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement
in connection therewith during the prohibition period in Section 4.12(a) herein, and provided that any such issuance shall only be to
a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset
in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities. Notwithstanding the foregoing, any securities issued after the 90 day
period referred to in Section 4.12(a) pursuant to a shelf registration statement on Form S-3 or any amendment or supplement thereto, as
referred to in Section 4.12(a), below, shall also be considered an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend Removal Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreement</U>&rdquo;
means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and executive officers, in the form
of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share Purchase
Price</U>&rdquo; equals $6, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other
similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means A.G.P./Alliance Global Partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Rights
Agreement</U>&rdquo; shall have the meaning ascribed to such term in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means a resale registration statement meeting the requirements of the Registration Rights Agreement and covering the resale by the Purchasers
of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Shares purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in
immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB
or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Lock-Up Agreement, the Registration Rights Agreement and all exhibits and schedules thereto and hereto and any
other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Computershare Trust Company, N.A., and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable Rate Transaction</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.12(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE II.<BR>
PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>. On the
Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of approximately $2.52 million of Shares. Each Purchaser shall deliver to the Company, via wire transfer, immediately
available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser,
and the Company shall deliver to each Purchaser its respective Shares, as determined pursuant to Section 2.2(a), and the Company and each
Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions
set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of the Placement Agent or such other location as the parties
shall mutually agree.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) On or prior to the Closing
Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) this Agreement duly executed
by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) a legal opinion of Company
Counsel, in a form reasonably acceptable to the Placement Agent and Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) a copy of the irrevocable
instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, in book entry form (unless otherwise
requested by the Purchasers) a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase
Price, registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) the Company&rsquo;s wire
instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) the Lock-Up Agreements
; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vi) the Registration Rights
Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) On or prior to the Closing
Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) this Agreement duly executed
by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) the Registration Rights
Agreement by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) such Purchaser&rsquo;s
Subscription Amount by wire transfer to the account specified by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The obligations of
the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;the accuracy in all
material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects)
on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in
which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) all obligations, covenants
and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) the delivery by each
Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The respective obligations
of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;the accuracy in all
material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects)
when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date
therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) all obligations, covenants
and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) the delivery by the
Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) there shall have been
no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)&nbsp;from the date hereof
to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading
Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been
suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or any
Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall
there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in
its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations and
Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof
and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of
the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Subsidiaries</U>. All
of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports or have otherwise been disclosed to Purchasers
by the Company. The Company owns, directly or indirectly, all of its capital stock or other equity interests of each Subsidiary free and
clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Organization and Qualification</U>.
The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of
any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.
Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect
on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken
as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Authorization; Enforcement</U>.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement
and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated
hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the
Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other than in connection with
the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have
been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>No Conflicts</U>. The
execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance
and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict
with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other
organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or
both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary,
or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or
otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or
any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule,
regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a
Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company
or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Filings, Consents and
Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section
4.4 of this Agreement, (ii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities
and the listing of the Shares for trading thereon in the time and manner required thereby, if any; (iii) the registration statement required
to be filed by the Registration Rights Agreement; and (iv) the filing of Form D with the Commission and such filings as are required to
be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Issuance of the Securities</U>.
The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly
and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer
provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of shares
of Common Stock issuable pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
Except as disclosed in the SEC Reports, the Company has not issued any capital stock since its most recently filed periodic report under
the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance
of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or
exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No
Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as set forth in Schedule 3.1(g) or as a result of the purchase and sale of the Securities,
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or
capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares
of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the
Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument
upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or
any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does
not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the
outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued
in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive
rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of
Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or
other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the
Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>SEC Reports; Financial
Statements</U>. Except as set forth on Schedule 3.1(h), the Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the one year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred
to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has
filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all
material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed,
contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been
an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply
in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto
as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified
in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required
by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Material Changes;
Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC
Reports, except as set forth on <U>Schedule 3.1(i) or in the SEC Reports</U>, (i) there has been no event, occurrence or development that
has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with
past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or
made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>,
no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist
with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial
condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made
or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Litigation</U>. Except
as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member
of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of
its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Environmental Laws</U>.
The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection
of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances
or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees,
demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued,
entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with
all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could
be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Regulatory Permits</U>.
The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local
or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure
to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;),
and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material
Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and
clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the
use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state
or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Intellectual Property</U>.
The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary
or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could
have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of
any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company,
all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) <U>Insurance</U>. The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the Company nor any Subsidiary has any
reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Transactions with
Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with
the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing
for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee
or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits,
including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) <U>Sarbanes-Oxley; Internal
Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific
authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. Except
as set forth in Schedule 3.1(s), the Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and
procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the
Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under
the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on
their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial
reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably
likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) <U>Certain Fees</U>. Except
for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company
or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with
respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees
or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in
connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) <U>Private Placement</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration under the Securities
Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale
of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) <U>Investment Company</U>.
The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate
of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct
its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company
Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w) <U>Registration Rights</U>.
Other than to each of the Purchasers pursuant to the Registration Rights Agreement, no Person has any right to cause the Company or any
Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)&nbsp;<U>Listing and Maintenance
Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no
action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under
the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except
as disclosed in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market
on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. Except as set forth in Schedule 3.1(x), the Company is, and has no reason to believe that it will
not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently
eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current
in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic
transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y) <U>Application of Takeover
Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover
provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation
that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising
their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of the Securities
and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z) <U>Disclosure</U>. Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents and the representations
made in Section 3.1(i), the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers
or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The
Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated
by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser
makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically
set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa)&nbsp;<U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under
the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the
Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Indebtedness</U>.
<U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary,
or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means
(x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable or accrued payroll liabilities
incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of
business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance
with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Tax Status</U>. The
Company and its Subsidiaries each (i) has made or filed all material United States federal, state and local income and all foreign income
and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all material taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent
to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due
by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>No General Solicitation</U>.
Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation
or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other &ldquo;accredited investors&rdquo;
within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other
unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Accountants</U>. The
Company&rsquo;s accounting firm is set forth in the SEC Reports. To the knowledge and belief of the Company, such accounting firm (i)
is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial
statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended June 30, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>No Disagreements with
Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise,
between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect
to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under
any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>Acknowledgment Regarding
Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that, to its knowledge, each of the Purchasers is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that, to its knowledge, no Purchaser is acting as a financial advisor or fiduciary of the Company
(or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(g) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked
by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified term, (ii)
past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo;
transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of
the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which
any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv)
each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various
times during the period that the Securities are outstanding and (z) such hedging activities (if any) could reduce the value of the existing
stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted.&nbsp;The Company
acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj)&nbsp;<U>Regulation M
Compliance</U>.&nbsp;The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any
action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the
sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the
Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the
Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement agent in connection with
the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>FDA</U>. As to each
product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;FDA&rdquo;) under the Federal Food, Drug and Cosmetic
Act, as amended, and the regulations thereunder (&ldquo;FDCA&rdquo;) that is manufactured, packaged, labeled, tested and/or distributed
by the Company or any of its Subsidiaries (each such product, a &ldquo;Pharmaceutical Product&rdquo;), such Pharmaceutical Product is
being manufactured, packaged, labeled, tested and/or distributed by the Company in compliance with all applicable requirements under FDCA
and similar laws, rules and regulations relating to registration, investigational use, licensure, or application approval, good manufacturing
practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing
of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or,
to the Company&rsquo;s knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding,
charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries
has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the licensure,
registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the
labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of,
or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes
a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the
Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or
any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the
Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the
FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States
of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or
clearing for marketing any product being developed or proposed to be developed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll)&nbsp;<U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Stock Option Plans</U>.
Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with the terms of the
Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date
such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option
plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly
grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement
of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is
subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes
and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect
to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>No Disqualification
Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of
the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated
on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company
in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;)
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures
provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ss) <U>Other Covered Persons</U>.
Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(tt) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating
to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations and
Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date
hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Organization; Authority</U>.
Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws
of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power
and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the
transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability
company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly
executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally
binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Own Account</U>. Such
Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered under the Securities Act
or any applicable state securities law and is acquiring the Securities as principal for its own account and not with a view to or for
distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law,
has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities
law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of
such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable
federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Purchaser Status</U>.
At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, either: (i) an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo;
as defined in Rule 144A(a) under the Securities Act. Such Purchaser hereby represents that neither such Purchaser nor any of its Rule
506(d) Related Parties (as defined below) is a &ldquo;bad actor&rdquo; within the meaning of Rule 506(d) promulgated under the Securities
Act. For purposes of this Agreement, &ldquo;Rule 506(d) Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad Actor
disqualification&rdquo; provision of Rule 506(d) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Experience of Such
Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in
business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>General Solicitation</U>.
Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the
Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or,
to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Access to Information</U>.
Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules
thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive
answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and
risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations,
business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain
such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make
an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent
nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities nor
is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation
as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp;In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Certain Transactions
and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person
acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including
Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first received a term
sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions
contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document, or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Transfer Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Securities may only
be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant
to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as
contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected
by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to
the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As
a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights
and obligations of a Purchaser under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Purchasers agree to
the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS SECURITY HAS NOT BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT
IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured
Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal
opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall
be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation
as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including,
if the Securities are subject to registration pursuant to Section 4.4 of this Agreement, the preparation and filing of any required prospectus
supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the
list of selling stockholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Certificates evidencing
the Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while a registration statement
(including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following any
sale of such Shares pursuant to Rule 144 and the Company is then in compliance with the current public information required under Rule
144, (iii) if such Shares are eligible for sale may be sold under Rule 144, without the requirement for the Company to be in compliance
with the current public information required under Rule 144 as to such Shares and without volume or manner-of-sale restrictions, or (iv)
if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser
promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by
a Purchaser, respectively. If the Shares may be sold under Rule 144 and the Company is then in compliance with the current public information
required under Rule 144, or if the Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with
the current public information required under Rule 144 as to such Shares or if such legend is not otherwise required under applicable
requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission), then
such Shares shall be issued free of all legends. The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly
after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder or if reasonably required by
a Purchaser. The Company agrees that following the Effective Date or at such time as such legend is no longer required under this Section
4.1(c), it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares
issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser
a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its
records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4.1. Certificates
for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account
of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;Standard
Settlement Period&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading
Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Shares issued with a restrictive
legend. The Purchaser shall provide the Company written notice of a removal request (the &ldquo;<B>Request Notice</B>&rdquo;) at least
two (2) Trading Days prior to delivery of the legended Share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;In addition to such
Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and not as
a penalty, for each $1,000 of Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer
Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading
Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date (or, of later, four
days after the Request Notice date) until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and
deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to
the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of
all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion
of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then,
an amount equal to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket
expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any)
(the &ldquo;<U>Buy-In Price</U>&rdquo;) over the product of (A) such number of Shares that the Company was required to deliver to such
Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the
period commencing on the date of the delivery by such Purchaser to the Company of the applicable Shares and ending on the date of such
delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) Each Purchaser, severally
and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant to either the
registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom,
and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set
forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth in this
Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Furnishing of Information;
Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) For at least two years
after the Closing Date, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange
Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements
of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) At any time during the
period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities of a Purchaser
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy
any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to that Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to one percent (1.0%) of the aggregate
Subscription Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every thirtieth (30<SUP>th</SUP>)
day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure
is cured and (b) such time that such public information is no longer required for that Purchaser to transfer the Shares pursuant to Rule
144.&nbsp;The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as &ldquo;<U>Public
Information Failure Payments</U>.&rdquo;&nbsp;Public Information Failure Payments shall be paid on the earlier of (i) the last day of
the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>) Business Day
after the event or failure giving rise to the Public Information Failure Payments is cured.&nbsp;In the event the Company fails to make
Public Information Failure Payments in a timely manner, other than during the pendency of any bona fide dispute over whether an alleged
Public Information Failure has occurred, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated
for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public
Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Integration</U>. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes
of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other
transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Securities Laws Disclosure;
Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated
hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within
the time required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that
it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its
Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by
the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any
and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries
or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers or any of their
Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing any other press
releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release
nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser,
or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other
party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose
the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading
Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with (i) any
registration statement contemplated by this Agreement and (ii) the filing of final Transaction Documents with the Commission and (b) to
the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with
prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Non-Public Information</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be
disclosed pursuant to Section 4.4, and except for representations made under Section 3.1(i), the Company covenants and agrees that neither
it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes,
or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented
to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that
the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants
and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers,
directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser
shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Use of Proceeds</U>.
The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate and working capital purposes and
shall not use such proceeds: (a) for the redemption of any Common Stock or Common Stock Equivalents, (b) for the settlement of any outstanding
litigation or (c) in violation of FCPA or OFAC regulations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Indemnification of
Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers,
shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such
titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section
15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or
employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title
or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating
to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other
Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates,
by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated
by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against
any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify
the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent
that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a
material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable
to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written
consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage
or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements
made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8
shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Reservation of Common
Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant
to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Listing of Common
Stock</U>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market
on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares on such
Trading Market and promptly secure the listing of all of the Shares on such Trading Market. The Company further agrees, if the Company
applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and will
take such other action as is necessary to cause all of the Shares to be listed or quoted on such other Trading Market as promptly as possible.
The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market
and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading
Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company
or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company
or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 [Reserved]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Subsequent Equity
Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) From the date hereof until
90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce
the issuance or proposed issuance of any Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment
or supplement thereto, other than the Prospectus Supplement or (A) a registration statement on Form S-8 with respect to a shareholder
approved equity incentive plan or (B) the registration statement described in Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) From the date hereof until
six (6) months following the Effective Date, the Company shall be prohibited from effecting or entering into an agreement to effect any
issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving
a Variable Rate Transaction. &ldquo;Variable Rate Transaction&rdquo; means a transaction in which the Company (i) issues or sells any
debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares
of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with
the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities,
or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of
such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of
the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not
limited to, an equity line of credit, whereby the Company may issue securities at a future determined price. Any Purchaser shall be entitled
to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect
damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Notwithstanding the foregoing,
this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13&nbsp;<U>Equal Treatment
of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to
amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered
to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to
each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as
a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14&nbsp;<U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement
are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain
the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules.&nbsp;Notwithstanding
the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees
that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by
this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall
have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance
of the initial press release as described in Section 4.4.&nbsp;Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made
the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15 <U>Form D; Blue Sky Filings</U>.
The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof,
promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order
to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under applicable securities or &ldquo;Blue
Sky&rdquo; laws of the states of the United States and shall provide evidence of such actions promptly upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16 <U>[Reserved] </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17 <U>[Reserved] </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.18 <U>Lock-Up Agreements</U>.
The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements without the prior written consent
of the Placement Agent, except to extend the term of the lock-up period, and shall enforce the provisions of each Lock-Up Agreement in
accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly
use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V.<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Termination</U>.&nbsp;This
Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees and Expenses</U>.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any
fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser),
stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect
to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 <U>Notices</U>. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed
given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile at the
facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m.
(New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto on
a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party
to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains material, non-public
information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5&nbsp;<U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial Subscription
Amounts hereunder (or, prior to the Closing Date, the Company and each Purchaser) or, in the case of a waiver, by the party against whom
enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely
impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall
also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to
be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>. The headings
herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors and Assigns</U>.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities,
provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>No Third-Party Beneficiaries</U>.
The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations
and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except
as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>. The
representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page were an original
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission and Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement of Securities</U>.
If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to
be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.
The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>. In addition
to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment Set Aside</U>.
To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces
or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents
the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that
each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and
not between the Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Liquidated Damages</U>.&nbsp;The
Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing
obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding
the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall
have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21 <B><U>WAIVER OF JURY
TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY
AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES
FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Precision Optics Corporation, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><U>Address for Notice</U>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; width: 2%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 35%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;<I>/s/ Joseph N. Forkey</I></FONT></TD>
    <TD STYLE="vertical-align: top; width: 20%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 43%"><FONT STYLE="font-size: 10pt">Precision Optics Corporation, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: Joseph N. Forkey</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Attn: Joseph N. Forkey, President and CEO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: President and CEO</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">22 East Broadway</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gardner, MA 01440-3338</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4"><FONT STYLE="font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">Precision
Optics Corporation, Inc.</FONT> SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 40%"><FONT STYLE="font-size: 10pt">Name of Purchaser:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><I>Signature of Authorized Signatory of Purchaser:</I></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Title of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Email Address of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Address for Notice to Purchaser:</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Delivery of Securities to Purchaser
(if not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EIN Number: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Schedule 3.1(g)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Capitalization</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Precision Optics Corporation, Inc.</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro-Forma Capitalization Table</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 13, 2023</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 2%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 32%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 12%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 12%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 9%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 3%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 10%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 2%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 10%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 8%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-left: Black 1pt solid; background-color: #D9E1F2">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent of</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent of</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-left: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="white-space: nowrap; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total&nbsp;&nbsp;</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fully</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fully</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Diluted</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Options</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #FCE4D6; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Diluted</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #FCE4D6; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dolphin Asset Management Corp</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,712</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.96%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.25%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;561,712 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hershey Strategic Capital, LP</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">328,826</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.83%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.83%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;328,826 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stuart Sternberg</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">294,822</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.23%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.33%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;294,822 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MHW Partners, LP (PWoodward)</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">224,671</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.98%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.30%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;224,671 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Norman, Sandra &amp; Brian Pessin Group</P></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">896,728</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.9%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.17%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;896,728 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,306,759</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>40.89%</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>33.88%</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,306,759 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.9%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Officers &amp; Directors</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Woodward, Chairman</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90,000 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90,000 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joe Forkey, CEO/Director</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,847</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.77%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;183,333 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;304,180 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dick Miles, Director</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,037</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.09%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.07%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60,998 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66,035 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.0%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew Miclot, Director</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59,998 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59,998 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.9%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Anania, Director</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">205,771</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.64%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.02%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26,666 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;232,437 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeff DiRubio, VP S&amp;M</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,000</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.91%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;74,999 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;136,999 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.0%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mangadu Divaker, Pres, Ross Optical Division</P></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;41,666 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;41,666 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mahesh Lawande, COO</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60,000 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60,000 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.9%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wayne Coll, CFO</FONT></TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50,000 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50,000 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #D9E1F2; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>393,655</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.98%</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.78%</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;647,660 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,041,315 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #D9E1F2">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; background-color: #D9E1F2; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #D9E1F2; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #D9E1F2; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,940,581</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.13%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.18%</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;520,970 </FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,461,551</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.8%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #D9E1F2">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; background-color: #D9E1F2; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #D9E1F2; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-left: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 2.25pt double; border-left: Black 1pt solid; background-color: #D9E1F2; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5,640,995</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 2.25pt double; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>100.00%</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 2.25pt double; background-color: #D9E1F2; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>82.84%</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-left: Black 1pt solid; border-bottom: Black 2.25pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,168,630</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 2.25pt double; border-left: Black 1pt solid; background-color: #FCE4D6"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6,809,625 </FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 2.25pt double; background-color: #FCE4D6; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #D9E1F2; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: Black 1pt solid; background-color: #D9E1F2">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D9E1F2">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: Black 1pt solid; border-left: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #FCE4D6">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Schedule 3.1(h)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SEC Reports; Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&rsquo;s Current Report on Form 8-K
regarding the appointment of Mahesh Lawande as Chief Operating Officer, which was due by April 28, 2023, was filed on May 9, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Schedule 3.1(i)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Material Changes; Undisclosed Events, Liabilities
or Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Schedule 3.1(j)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Litigation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Schedule 3.1(o)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Title to Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The indebtedness referenced in Schedule 3.1(bb)(i)-(iii)
is subject to a lien by Main Street Bank on all assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Schedule 3.1(r)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Transactions with Affiliates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As partial consideration for the October 2021 acquisition
of Lighthouse Imaging, and as part of an Asset Purchase Agreement dated as of October 4, 2021, the Company agreed to pay an earn-out in
two installments contingent on the Lighthouse Imaging division achieving stated levels of gross margin for the given twelve month earn-out
period. Peter V. Anania, a member of the Company&rsquo;s board of directors, holds certain rights to participate in the earn-out.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Schedule 3.1(s)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sarbanes-Oxley; Internal Accounting Controls</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the date of the Stock Purchase Agreement
and as of the Closing date, the Company is in compliance and has adequate internal accounting controls.&nbsp; The Company determined that
as of the March 31, 2023 (the &ldquo;Evaluation Date&rdquo;) it had a material weakness.&nbsp; The Company has made changes since the
Evaluation Date to materially improve its controls to mitigate the material weakness.&nbsp; The report of the material weakness is as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the Company&rsquo;s
review of the results for the fiscal quarter ended March 31, 2023, errors were identified in the Company&rsquo;s accruals of costs associated
with services provided by third-party contractors on certain development projects. Those errors caused an understatement of costs of goods
sold for the quarters ended September 30, 2022, and December 31, 2022, for which the Company has concluded such error is not material
to those previously reported financial statements. However, because of the significance of these items, and to facilitate comparisons
among periods, the Company decided to revise the previously issued first and second quarter unaudited condensed consolidated financial
information by increasing accounts payable and cost of goods sold by $85,213 and $125,752 in the quarters ended September 30, 2022, and
December 31, 2022, respectively. Such quarterly and year to date financial statements will be revised in subsequent filings with the Securities
and Exchange Commission that include such statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To address and remediate the
material weakness in internal control over financial reporting described above, the Company has implemented processes to improve its accounts
payable controls and documentation for the recognition of costs incurred for services performed by outside contractors and matching those
costs, when applicable, to fiscal periods in which those services are billed to its customers. Specifically, the Company has implemented
procedures to document the receipt of non-physical work product by its outside contractors, accrue for services performed by outside contractors
when vendor invoices for such services have not yet been received, and to review billings to customers to ensure related contractor billings
are expensed in the same period. The Company&rsquo;s Chief Executive Officer and Chief Financial Officer will monitor such accruals in
future quarters to confirm that these steps have properly remediated the material weakness in the timing of third-party expense accruals.
The Company believes that the steps outlined above strengthen its internal control over financial reporting and mitigate the material
weakness described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Schedule 3.1(x)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Listing and Maintenance Requirements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Schedule 3.1(bb)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Indebtedness</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>$2,600,000 Promissory Note dated October 4, 2021, from Company to Main Street Bank.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">$750,000 Promissory Note dated June 2, 2023, from Company to Main
Street Bank.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>$1,250,000 Demand Revolving Line of Credit dated June 2, 2023, from Company to Main Street Bank.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>$511,000 in the present value of various lease payments requiring capitalization under GAAP.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 34; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>poci_ex1002.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT, BY AND AMONG PRECISION OPTICS CORPORATION, INC. AND SEVERAL INVESTORS, DATED JUNE 15, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of June 15, 2023, between Precision Optics Corporation, Inc., a Massachusetts
corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of June 15, 2023, between the Company and the Purchasers named therein (the &ldquo;<U>Purchase
Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used and
not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 45<SUP>th</SUP> &nbsp;calendar
day following the Filing Date (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 75th<SUP>&nbsp;</SUP>calendar day
following the Filing Date) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or
Section 3(c), the 15<SUP>th</SUP>&nbsp;calendar day following the date on which an additional Registration Statement is required to be
filed hereunder (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 60<SUP>th</SUP>&nbsp;calendar day following the
date hereof);&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that in the event the Company is notified by the Commission that one or more
of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date
as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such date precedes
the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness
Date shall be the next succeeding Trading Day. Notwithstanding the foregoing, if the Company reasonably concludes that it is ineligible
to file a Registration Statement on Form S-3, then &ldquo;Effectiveness Date&rdquo; means the 90<SUP>th</SUP> calendar day following the
Filing Date. The Company agrees to use reasonable efforts to obtain a waiver from the Commission Staff of any defects to eligibility to
file on Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the 20<SUP>th</SUP> calendar day following
the Closing Date; provided that if the Company reasonably concludes that it is ineligible to file a Registration Statement on Form S-3,
then &ldquo;Filing Date&rdquo; means the 30<SUP>th</SUP> calendar day following the Closing Date. With respect to any additional Registration
Statements which may be required pursuant to Section 2(c) or Section 3(c), &ldquo;Filing Date&rdquo; means the earliest practical date
on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan of
Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) the Shares, and (b) any securities issued or then issuable upon any
share split, dividend or other distribution, recapitalization or similar event with respect to the foregoing;&nbsp;<U>provided, however</U>,
that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the
effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement
with respect to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable
Securities have been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities
have been previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale
restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed,
delivered and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any securities issuable upon
exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time
held by any Affiliate of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling
Shareholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section&nbsp;3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shelf
Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all
of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous
basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible
to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in
accordance herewith, subject to the provisions of Section 2(e)) and shall contain substantially the &ldquo;<U>Plan of Distribution</U>&rdquo;
attached hereto as&nbsp;<U>Annex A</U>&nbsp;and substantially the &ldquo;<U>Selling Shareholder</U>&rdquo; section attached hereto as&nbsp;<U>Annex
B</U>;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without
such Holder&rsquo;s express prior written consent. Subject to the terms of this Agreement, the Company shall use its best efforts to cause
a Registration Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under
the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date,
and shall use its best efforts to keep such Registration Statement continuously effective under the Securities Act until the date that
all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may
be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance
with the current public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion
letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;).
The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day.
The Company shall immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on the same
Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness
of such Registration Statement. The Company shall, by 9:30 a.m. (New York City time) on the Trading Day after the effective date of such
Registration Statement, file a final Prospectus with the Commission as required by Rule&nbsp;424. Failure to so notify the Holder within
one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event under
Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the registration obligations set forth in Section&nbsp;2(a), if the Commission informs the Company that all of the Registrable Securities
cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement,
the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the
Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered
by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary offering,
subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the provisions
of Section 2(d) with respect to the payment of liquidated damages;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that prior to filing such
amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the Registrable
Securities in accordance with the SEC Guidance, including without limitation, Securities Act Rules Compliance and Disclosure Interpretation
Question 612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission or
any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the
registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable
Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;First,
the Company shall reduce or eliminate any securities to be included other than Registrable Securities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Second,
the Company shall reduce Registrable Securities represented by Shares (applied, in the case that some Shares may be registered, to the
Holders on a pro rata basis based on the total number of unregistered Shares held by such Holders).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">In the event of
a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations
as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing,
the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the
Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form available to register
for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If:
(i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement
without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company shall
be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration of
a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5) Trading
Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement
will not be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement,
the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of
such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment
is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale
all of the Registrable Securities, subject to the cutback limitations set forth in Section 2(c) of this Agreement, is not declared effective
by the Commission by the Effectiveness Date of the Initial Registration Statement, or (v) after the effective date of a Registration Statement,
such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such Registration
Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more
than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar
days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses
(i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is
exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded, and for purpose of clause (v)
the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;),
then, in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly
anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured,
the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.0%
multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any
partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon
at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily
from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial
liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of
an Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale
of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3 as soon
as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until
such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any
Underwriter without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Company&rsquo;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not
less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the
filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to
be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as&nbsp;<U>Annex
C&nbsp;</U>(a &ldquo;<U>Selling Shareholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the
Filing Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials
in accordance with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register
for resale under the Securities Act all of the Registrable Securities, (ii)&nbsp;cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the
applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by
an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and,
in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such
notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii)&nbsp;of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for
that purpose, (iv)&nbsp;of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(v)&nbsp;of the occurrence of any event
or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement
made in a Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in
any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of
a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect to the
Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best interest of
the Company to allow continued availability of a Registration Statement or Prospectus;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that
in no event shall any such notice contain any information which would constitute material, non-public information regarding the Company
or any of its Subsidiaries and the Company agrees that the Holders shall not have any duty of confidentiality to the Company or any of
its Subsidiaries and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis of such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Use
its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities
for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by
each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any
amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting a filing
with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder, and the Company shall pay
the filing fee required by such filing within two (2) Business Days of receipt of a request therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with
the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of such
Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States
as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the
Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of
the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account
the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its shareholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section
3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall
suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly
as is practicable. The Company shall be entitled to exercise its right under this Section 3(k) to suspend the availability of a Registration
Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period
not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and
the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prospectus in connection with any disposition
of Registrable Securities and take such other actions as may be reasonably necessary to facilitate the registration of the Registrable
Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use its reasonable best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration
of the resale of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially
owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the
shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable
Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s request, any liquidated
damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of
such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Expenses</U>. All fees and expenses incident to the performance of or compliance with this Agreement by the Company shall be borne by
the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to
in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees
and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with the Commission,
(B) with respect to filings required to be made with any Trading Market on which the shares of Common Stock are then listed for trading,
and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without
limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable
Securities), and (D) if not previously paid by the Company with respect to any filing that may be required to be made by any broker through
which a Holder intends to make sales of Registrable Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving
no more than a customary brokerage commission in connection with such sale, (ii) printing expenses (including, without limitation, expenses
of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of
counsel for the Company, (v)&nbsp;Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses
of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In
addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions
contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal
or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable
Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker or similar commissions
of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the
officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a
result of a pledge or any failure to perform under a margin call), investment advisors and employees (and any other Persons with a functionally
equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each of them, each Person
who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers,
directors, members, shareholders, partners, agents and employees (and any other Persons with a functionally equivalent role of a Person
holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted
by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable
attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred in investigating, preparing or defending
against any litigation, commence or threatened, or any claim, arising out of or relating to (1) any untrue or alleged untrue statement
of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange
Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this
Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon information
regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information
relates to such Holder or such Holder&rsquo;s proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto
(it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of
the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after
the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder
and prior to the receipt by such Holder of the Advice contemplated in Section 6(c). The Company shall notify the Holders promptly of the
institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement
of which the Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf
of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section
6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents
and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law,
from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of
a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)
to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Shareholder
Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such
Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose),
such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than
the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and
the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such
Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct
of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the
&ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including
the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection
with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party
of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a
court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially
and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">An Indemnified Party
shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing
to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ
counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including
any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably
believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at
the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable
fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall
not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably
withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of
any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release
of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Subject to the terms
of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred
in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid
to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that the
Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions
for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal
or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>.
If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party
harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions,
statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such
Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including
any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by,
or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative intent, knowledge,
access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party
as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&rsquo;
or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified
for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The parties hereto
agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission)
received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The indemnity and
contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified
Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the
Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery
of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder agrees that
monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions
of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall
not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security holders
(other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than
the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities are registered
pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall not prohibit
the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new securities are
registered on any such existing registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Discontinued
Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the
occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of
such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the Company
that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges that
any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject
to the provisions of Section 2(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Piggy
Back Registrations</U>. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering all
of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating
to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form
S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans, then the Company shall deliver to the Holder a written notice of such determination and, if within
fifteen (15) days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include
in such registration statement all or any part of such Registrable Securities such Holder requests to be registered; provided, however,
that the Company shall not be required to register any Registrable Securities pursuant to this Section 6(d) that are eligible for resale
pursuant to Rule 144 (without volume restrictions or current public information requirements) promulgated by the Commission pursuant to
the Securities Act or that are the subject of a then effective Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments
and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the
Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes
any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group
of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or
amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall
be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted
from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect
to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights
of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of the first
sentence of this Section 6(d). No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of this Agreement unless the same consideration also is offered to all of the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth
in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the
parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder
without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective
rights hereunder in the manner and to the Persons as permitted under Section&nbsp;5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company
or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would
have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Neither
the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with respect to any
of its securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Execution
and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in
accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or
affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Independent
Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations
of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder
hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder
pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind
of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to
such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.
Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,
and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action or
decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do so by
any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder,
solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Precision Optics Corporation, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 45%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><I>/s/ Joseph N. Forkey</I>&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;Joseph N. Forkey</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">President and CEO</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO Precision Optics Corporation, Inc., RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Holder: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Holder</I>:
__________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Plan of Distribution</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Shareholder (the
&ldquo;<U>Selling Shareholder</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest may, from
time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange, market or
trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling
Shareholder may use any one or more of the following methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="width: 92%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately negotiated transactions;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement of short sales;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in transactions through broker-dealers that agree with the Selling Shareholders to sell a specified number of such securities at a stipulated price per security;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Shareholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Shareholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in
compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Shareholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Shareholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Shareholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Shareholders has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Shareholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective until the earlier of (i) the date on which the securities may be resold by the Selling Shareholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the shares of Common Stock for the applicable restricted period, as defined in Regulation M, prior to
the commencement of the distribution. In addition, the Selling Shareholders will be subject to applicable provisions of the Exchange Act
and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the shares of Common
Stock by the Selling Shareholders or any other person. We will make copies of this prospectus available to the Selling Shareholders and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by
compliance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SELLING SHAREHOLDERS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of Common Stock
being offered by the selling shareholders are those previously issued to the selling shareholders. For additional information regarding
the issuances of those shares of Common Stock, see &ldquo;Private Placement&rdquo; in the Purchase Agreement. We are registering the shares
of Common Stock in order to permit the selling shareholders to offer the shares for resale from time to time. Except for the ownership
of the shares of common stock and warrants, the selling shareholders have not had any material relationship with us within the past three
years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling stockholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling stockholders.
The second column lists the number of shares of common stock beneficially owned by each selling stockholder, based on its ownership of
the shares of common stock and warrants, as of ________, 2023, assuming exercise of the warrants held by the selling stockholder on that
date, without regard to any limitations on exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of Common Stock being offered by this prospectus by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale of the sum of the number
of shares of common stock issued to the selling stockholders in the &ldquo;Private Placement&rdquo; described in the Purchase Agreement.
The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 37%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name of Selling Shareholder</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of shares of Common Stock Owned Prior to Offering</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of shares of Common Stock Owned After Offering</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B><U>Annex C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Precision
Optics Corporation, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Selling Shareholder Notice and Questionnaire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of shares of Common Stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Precision Optics Corporation, Inc. (the &ldquo;<U>Company</U>&rdquo;),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale under Rule&nbsp;415 of the
Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in accordance with the terms
of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this document is annexed. A copy
of the Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms
not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling shareholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling shareholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned beneficial owner (the &ldquo;<U>Selling
Shareholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned by it in the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned hereby provides the following information to the Company
and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>QUESTIONNAIRE</U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Name.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="width: 94%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Full Legal Name of Selling Shareholder</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Address for Notices to Selling Shareholder:</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 100%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Telephone:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 90%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fax:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 95%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contact Person:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 85%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Broker-Dealer Status:</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Are you a broker-dealer?</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes &nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &nbsp;&nbsp;&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes &nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &nbsp;&nbsp;&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Note:</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Are you an affiliate of a broker-dealer?</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes &nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &nbsp;&nbsp;&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes &nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &nbsp;&nbsp;&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Note:</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>4.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Beneficial Ownership of Securities of the Company Owned by the Selling Shareholder.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Type and Amount of other securities beneficially owned by the Selling Shareholder:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>5.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Relationships with the Company:</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">State any exceptions here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 97%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned agrees to promptly notify the
Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any
time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of
any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By signing below, the undersigned consents to
the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration
Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such information will
be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus
and any amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 46%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial Owner:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 33%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 43%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF
THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>poci_ex1003.htm
<DESCRIPTION>PLACEMENT AGENT AGREEMENT, BY AND BETWEEN PRECISION OPTICS CORPORATION, INC. AND A.G.P./ALLIANCE GLOBAL PARTNERS, DATED JUNE 15, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0 0pt 0pt">Exhibit 10.3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right; text-indent: 0.5in">June 15, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Precision Optics Corporation,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Joseph N. Forkey, President and Treasurer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">22 East Broadway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gardner, Massachusetts 01440-3338&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Mr. Forkey:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter (the &ldquo;<B>Agreement</B>&rdquo;)
constitutes the agreement between A.G.P./Alliance Global Partners (the &ldquo;<B>Placement Agent</B>&rdquo;) and Precision Optics Corporation,
Inc., a Massachusetts corporation (the &ldquo;<B>Company</B>&rdquo;), that the Placement Agent shall serve as the exclusive placement
agent for the Company, on a &ldquo;reasonable best efforts&rdquo; basis, in connection with the proposed placement (the &ldquo;<B>Placement</B>&rdquo;)
of shares (the &ldquo;<B>Shares</B>&rdquo;) of the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;<B>Common Stock</B>&rdquo;).
The Securities actually placed by the Placement Agent are referred to herein as the &ldquo;<B>Placement Agent Securities</B>.&rdquo; The
terms of the Placement shall be mutually agreed upon by the Company and the purchaser of the Securities (the &ldquo;<B>Purchaser</B>&rdquo;),
and nothing herein constitutes that the Placement Agent would have the power or authority to bind the Company or the Purchaser, or an
obligation for the Company to issue any Securities or complete the Placement. The Company expressly acknowledges and agrees that the Placement
Agent&rsquo;s obligations hereunder are on a reasonable best efforts basis only and that the execution of this Agreement does not constitute
a commitment by the Placement Agent to purchase the Securities and does not ensure the successful placement of the Securities or any portion
thereof or the success of the Placement Agent with respect to securing any other financing on behalf of the Company. The Placement Agent
may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement. Certain affiliates
of the Placement Agent may participate in the Placement by purchasing some of the Placement Agent Securities. The sale of Placement Agent
Securities to the Purchaser will be evidenced by a securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) between
the Company and such Purchaser, in a form reasonably acceptable to the Company and the Purchaser. Capitalized terms that are not otherwise
defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers
of the Company will be available to answer inquiries from the prospective Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 1</U>.&nbsp;<U>REPRESENTATIONS
AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A. <U>Representations of the
Company</U>. With respect to the Placement Agent Securities, each of the representations and warranties (together with any related disclosure
schedules thereto) and covenants made by the Company to the Purchaser in the Purchase Agreement in connection with the Placement, are
hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement
and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents
and warrants that there are no affiliations with any FINRA (as defined below) member firm among the Company&rsquo;s officers, directors
or, to the knowledge of the Company, any five percent (5.0%) or greater securityholder of the Company, except as set forth in the Purchase
Agreement.<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B. <U>Covenants of the Company</U>.
The Company covenants and agrees to continue to retain (i) a firm of independent PCAOB registered public accountants for a period of at
least five (5) years after the Closing Date and (ii) a competent transfer agent with respect to the Common Stock for a period of five
(5) years after the Closing Date. In addition, from the date hereof until 90 days after the Effective Date, neither the Company nor any
Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common
Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, other than the Prospectus Supplement
or (A) a registration statement on Form S-8 with respect to a shareholder approved equity incentive plan or (B) the registration statement
described in Registration Rights Agreement This Section 1(B) shall not apply in respect of an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 2</U>. <U>REPRESENTATIONS
OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i) is a member in good standing of FINRA, (ii) is registered
as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the laws of the United States of America, applicable
to the offers and sales of the Placement Agent Securities by the Placement Agent, (iv) is and will be a corporate body validly existing
under the laws of its place of incorporation, and (v) has full power and authority to enter into and perform its obligations under this
Agreement. The Placement Agent will immediately notify the Company in writing of any change in its status with respect to subsections
(i) through (v) above. The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement hereunder in
compliance with the provisions of this Agreement and the requirements of applicable law. The Placement Agent represents and warrants that,
to its knowledge after reasonable investigation, each of the Purchasers is an &ldquo;accredited investor&rdquo; within the meaning of
Rule 501(a) under the Securities Act, and that the Placement Agent has not engaged in any marketing or sales activity that constitutes
a &ldquo;general solicitation&rdquo; or &ldquo;general advertising&rdquo; within the meaning of Rule 502(c) under the Securities Act</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 3</U>. <U>COMPENSATION</U>.
In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent and/or its respective designees
a cash fee of 7.0% of the aggregate gross proceeds raised from the sale of the Placement Agent Securities (the &ldquo;<B>Cash Fee</B>&rdquo;).
The Cash Fee shall be paid on the Closing Date. Concurrently out of the proceeds of the closing the Company also agrees to reimburse A.G.P
for accountable legal fees and other out-of-pocket expenses incurred by A.G.P in connection with the transaction in an amount not to exceed
$15,000, as well as non-accountable expenses (the &ldquo;<B>NAE</B>&rdquo;) including, but not limited to, IPREO software related expenses,
background check(s), marketing related expenses; i.e. roadshow, travel, et al. and any other expenses incurred by A.G.P. in connection
with the transaction, (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution
provisions of this Agreement). The total NAE allowances shall not exceed $5,000. A.G.P will provide an accounting of legal and out-of-pocket
expenses and NAE prior to payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 4</U>. <U>INDEMNIFICATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. To the extent permitted
by law, with respect to the Placement Agent Securities, the Company will indemnify the Placement Agent and its affiliates, stockholders,
directors, officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the reasonable
fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to this Agreement, except to the extent
that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment (not subject to
appeal) by a court of law to have resulted primarily and directly from the Placement Agent&rsquo;s fraud, willful misconduct or gross
negligence in performing the services described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. Promptly after receipt
by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which the Placement Agent
is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or of the commencement of such
action or proceeding, but failure to so notify the Company shall not relieve the Company from any obligation it may have hereunder, except
and only to the extent such failure results in the forfeiture by the Company of substantial rights and defenses. If the Company so elects
or is requested by the Placement Agent, the Company will assume the defense of such action or proceeding and will employ counsel reasonably
satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding the preceding sentence, the Placement
Agent will be entitled to employ counsel separate from counsel for the Company and from any other party in such action if counsel for
the Placement Agent reasonably determines that it would be inappropriate under the applicable rules of professional responsibility for
the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable fees and disbursements of no more
than one (1) such separate counsel will be paid by the Company, in addition to fees of local counsel. The Company will have the right
to settle the claim or proceeding provided that the Company will not settle any such claim, action or proceeding without the prior written
consent of the Placement Agent, which will not be unreasonably withheld. The Company shall not be liable for any settlement of any action
effected without its written consent, which will not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. The Company agrees to notify
the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement of any action or proceeding
relating to a transaction contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. If for any reason the foregoing
indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless, then the Company shall contribute
to the amount paid or payable by the Placement Agent as a result of such losses, claims, damages or liabilities in such proportion as
is appropriate to reflect not only the relative benefits received by the Company on the one hand and the Placement Agent on the other,
but also the relative fault of the Company on the one hand and the Placement Agent on the other that resulted in such losses, claims,
damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable by a party in respect of losses,
claims, damages and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending
any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the Placement Agent&rsquo;s share of the liability
hereunder shall not be in excess of the amount of fees actually received, or to be received, by the Placement Agent under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E. These indemnification provisions
shall remain in full force and effect whether or not the transaction contemplated by this Agreement is completed and shall survive the
termination of this Agreement, and shall be in addition to any liability that the Company might otherwise have to any indemnified party
under this Agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 5</U>. <U>ENGAGEMENT
TERM</U>. The Placement Agent&rsquo;s engagement hereunder will commence on the date hereof and continue through the Closing Date. The
date of termination of this Agreement is referred to herein as the &ldquo;<B>Termination Date</B>.&rdquo; In the event, however, in the
course of the Placement Agent&rsquo;s performance of due diligence it deems it necessary to terminate the engagement, the Placement Agent
may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason prior to the Termination
Date but will remain responsible for fees and expenses pursuant to Section 3 hereof and fees and expenses with respect to the Placement
Agent Securities, if sold in the Placement. Notwithstanding anything to the contrary contained herein, the provisions concerning the Company&rsquo;s
obligation to pay any fees or expenses actually earned pursuant to Section 3 hereof and the provisions concerning confidentiality, indemnification
and contribution contained herein will survive any expiration or termination of this Agreement. If this Agreement is terminated prior
to the completion of the Placement, all fees or expenses due to the Placement Agent shall be paid by the Company to the Placement Agent
on or before the Termination Date (in the event such fees or expenses are earned or owed as of the Termination Date). The Placement Agent
agrees not to use any confidential information concerning the Company provided to the Placement Agent by the Company for any purposes
other than those contemplated under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 6</U>. <U>PLACEMENT
AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement
is for the confidential use of the Company only in its evaluation of the Placement and, except as otherwise required by law, the Company
will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 7</U>. <U>NO FIDUCIARY
RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person or entity not
a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges and agrees that
the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities to the equity
holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement Agent hereunder,
all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 8</U>. <U>CLOSING</U>.
The obligations of the Placement Agent, and the closing of the sale of the Placement Agent Securities hereunder are subject to the accuracy,
when made and on the Closing Date, of the representations and warranties on the part of the Company contained herein and in the Purchase
Agreement, to the performance by the Company of its obligations hereunder and in the Purchase Agreement, and to each of the following
additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A. All corporate proceedings
and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement, the Placement
Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby with respect to the
Placement Agent Securities shall be reasonably satisfactory in all material respects to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B. The Placement Agent shall
have received from outside U.S. counsel to the Company each such counsel&rsquo;s written opinion with respect to the Placement Agent Securities,
addressed to the Placement Agent and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement Agent.
&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C. The Placement Agent shall
have received customary certificates of the Company&rsquo;s executive officers, as to the accuracy of the representations and warranties
contained in the Purchase Agreement, and a certificate of the Company&rsquo;s secretary certifying that each of the Company&rsquo;s charter
documents are true and complete, have not been modified and are in full force and effect; (ii) that the resolutions of the Company&rsquo;s
Board of Directors relating to the Placement are in full force and effect and have not been modified; and (iii) as to the incumbency of
the officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">D. The Common Stock shall be
registered under the Exchange Act in accordance with the terms of the Purchase Agreement and, as of the Closing Date, the Shares shall
be listed and admitted and authorized for trading on the Trading Market or other applicable U.S. national exchange and satisfactory evidence
of such action shall have been provided to the Placement Agent. The Company shall have taken no action designed to, or likely to have
the effect of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common
Stock from the Trading Market or other applicable U.S. national exchange, nor has the Company received any information suggesting that
the Commission or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">E. No action shall have been
taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would,
as of the Closing Date, prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially
and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other nature by any
federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance or sale
of the Placement Agent Securities or materially and adversely affect or potentially and adversely affect the business or operations of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">F. The Company shall have entered
into a Purchase Agreement with the Purchasers of the Placement Agent Securities and such agreement shall be in full force and effect and
shall contain representations, warranties and covenants of the Company as agreed upon between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">G. FINRA shall have raised no
objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company shall, if requested
by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s behalf, any necessary filing
with the FINRA Corporate Financing Department with respect to the Placement and pay all filing fees required in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of the conditions specified
in this Section 8 shall not have been fulfilled when and as required by this Agreement, all obligations of the Placement Agent hereunder
may be cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such cancellation shall be given to the
Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 9</U>. <U>GOVERNING
LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements
made and to be performed entirely in such State, without regard to its conflict of laws principles. This Agreement may not be assigned
by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of
the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising
under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought
into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and delivery of this
Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid
courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If either
party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or
proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 10</U>. <U>ENTIRE
AGREEMENT/MISCELLANEOUS</U>. This Agreement embodies the entire agreement and understanding between the parties hereto, and supersedes
all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined to be
invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision
of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except
by an instrument in writing signed by both the Placement Agent and the Company. The representations, warranties, agreements and covenants
contained herein shall survive the Closing Dates of the Placement and delivery of the Placement Agent Securities. This Agreement may be
executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature
shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force
and effect as if such facsimile or .pdf signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 11</U>. <U>NOTICES</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address
specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day
after the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto on
a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day following
the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 12</U>. <FONT STYLE="text-transform: uppercase"><U>Press
Announcements</U></FONT>. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference
the Placement and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials and on its
website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>The remainder of this page
has been intentionally left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please confirm that the foregoing
correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>A.G.P./ALLIANCE GLOBAL PARTNERS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By: &nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Thomas J. Higgins</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;Thomas J. Higgins</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Managing Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%">&nbsp;</TD>
    <TD STYLE="width: 48%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Address for notice:</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">590 Madison Avenue, 28th&nbsp;Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10022</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Thomas J. Higgins</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email:&nbsp;<U>thiggins@allianceg.com&nbsp;</U></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accepted and Agreed to as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the date first written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Precision Optics Corporation, Inc.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Joseph N. Forkey</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;Joseph N. Forkey</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">President and CEO</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><U>Address for notice</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Precision Optics Corporation,
Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Attn: Joseph N. Forkey, President
and CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">22 East Broadway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gardner, Massachusetts 01440-3338</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page to Placement
Agency Agreement.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>poci_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 1in; width: 138pt"></TD>
  <TD STYLE="width: 50%">&nbsp;<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PRECISION OPTICS CORPORATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">22 EAST BROADWAY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">GARDNER, MASSACHUSETTS 01440-3338</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">Telephone 978 / 630-1800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">Telefax 978 / 630-1487 &nbsp;</P>



</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: right; text-indent: 3in"><B>POC 23-0039</B></P>

<P STYLE="margin: 0">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Precision Optics Announces $2.52 Million Private
Placement of Common Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GARDNER, Mass, June 15, 2023 /PRNewswire/ -- Precision
Optics Corporation, Inc. (NASDAQ: POCI) (the &ldquo;Company&rdquo;), a leading designer and manufacturer of advanced optical instruments
for the medical and defense industries, today announced that it has entered into definitive agreements with institutional and accredited
investors for the purchase and sale of 420,000 shares of the Company&rsquo;s common stock pursuant to a private placement, resulting in
gross proceeds of approximately $2.52 million before deducting placement agent commissions and other estimated offering expenses. The
closing of the offering is expected to occur on or about June 20, 2023, subject to the satisfaction of customary closing conditions. The
definitive agreements contain a representation from the Company to the effect that there have been no material adverse developments with
respect to the Company since the date of filing of its most recent report on Form 10-Q.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A.G.P./Alliance Global Partners is acting as the
sole placement agent for the private placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offer and sale of the foregoing securities
is being made in a transaction not involving a public offering, and the securities have not been registered under the Securities Act of
1933, as amended (the &ldquo;Securities Act&rdquo;), or applicable state securities laws. Accordingly, the securities may not be offered
or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements
of the Securities Act and such applicable state securities laws. Under an agreement with the investors, the Company agreed to file a registration
statement with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) covering the resale of the shares of common stock to
be issued to the investors no later than 30 days after the closing and to use commercially reasonable efforts to have the registration
statement declared effective as promptly as practicable thereafter, and in any event no later than 90 days after the filing of the initial
registration statement in the event of a &ldquo;full review&rdquo; by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction
in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any
such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Precision Optics Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Founded in 1982, Precision Optics is a vertically
integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and
defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge
in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division's electronic imaging expertise
and its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and
manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables
next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced
and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical
robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a
wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging
its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards
and the optimization of size, weight and power. For more information, please visit www.poci.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains forward-looking statements
within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, statements regarding
the closing of the private placement of securities and the filing of a registration statement covering the resale of these securities.
Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition,
any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying
assumptions, are forward-looking statements. The words &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intends,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;plan,&rdquo; &ldquo;possible,&rdquo;
&ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; &ldquo;would&rdquo; and similar expressions
may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking
statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light
of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential
effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future
developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties
(some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially
different from those expressed or implied by these forward-looking statements, including risks that the closing conditions for the private
placement of the securities will not be achieved, the demand for the Company&rsquo;s products, global supply chains and economic activity
in general and other risks and uncertainties identified in the Company&rsquo;s filings with the SEC. Should one or more of these risks
or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects
from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements,
whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PRECISION OPTICS CORPORATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">22 East Broadway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gardner, Massachusetts 01440-3338</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Telephone: 978-630-1800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">LYTHAM PARTNERS, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Robert Blum</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Telephone: 602-889-9700</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">poci@lythampartners.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" #< :8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\(#X:ND:5P&1MEW>KE5!Q(CQV^3M962X1@0/T6_9,_8H_9U_8J\#?\(1\!O
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M[5DT[/HK6/;X%XZEQ1*>&Q,%"M%<WNWY91O9V3;::;5]7>]T>R445XC^W?\
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MU"^N%A@M8(U+/+([D*B*H+,Q(  ))P*:3D[(3DHJ[/E[_@KA_P %![3]@_\
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MI22;=]7=-W?J?MG$D<%6X3QD(<KA&E.R5K)QBW%*VBLTK+T/Y]?Q_G7[<_\
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M"491E9G1&4914HNZ84444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\QK_ /?*OUAHK;_7WBS_ *"?_)*?_P @<_\ Q#?@O_H%_P#)ZG_R9^3W_$,
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M=>KXF8:=+/XU7M."MZIM-?D_F>+X38JG6X;E16\*DK^C2:?YKY!1117YV?J
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M_8G_ &M=>_X2_P"-_P !M-O]=VL&U[3[B?3[R8F..-6FEM9(S<E$B14$WF!
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MU&^BN]E=Z*^_053%8:E6A1G-*<[\L6TG*VKY5N[+5VV6YZM1116)N%%%8WQ
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MG/WTO[E[$XC'9US>THU:G^Z-J<J7O7]NDFXI.SY.VO+[]KGU3^Q?^UA^V_\
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M_@EU\1_VQ=7_ &;/ /AL>%O';Z?;>$?AAHJZ)9ZC/)#ID<4DBLTG[PO<@/(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
AHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>poci-20230615.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaGE6aPty5522YkxvmR4fdmq3yol7/eOzCkipUOGQUUJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:POCI="http://poci.com/20230615" elementFormDefault="qualified" targetNamespace="http://poci.com/20230615">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://poci.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="poci-20230615_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="poci-20230615_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>poci-20230615_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>poci-20230615_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://poci.com/role/Cover" xlink:href="poci-20230615.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://poci.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140107843899088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 15,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PRECISION
OPTICS CORPORATION, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000867840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2795294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">22
    East Broadway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Gardner<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(978)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">630-1800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">POCI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>poci_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="poci-20230615.xsd" xlink:type="simple"/>
    <context id="From2023-06-15to2023-06-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000867840</identifier>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-06-15to2023-06-15">0000867840</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-06-15to2023-06-15">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-06-15to2023-06-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-06-15to2023-06-15">2023-06-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-06-15to2023-06-15">PRECISION OPTICS CORPORATION, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-06-15to2023-06-15">MA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-06-15to2023-06-15">001-10647</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-06-15to2023-06-15">04-2795294</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-06-15to2023-06-15">22     East Broadway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-06-15to2023-06-15">Gardner</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-06-15to2023-06-15">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-06-15to2023-06-15">01440</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-06-15to2023-06-15">(978)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-06-15to2023-06-15">630-1800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-06-15to2023-06-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-06-15to2023-06-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-06-15to2023-06-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-06-15to2023-06-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-06-15to2023-06-15">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-06-15to2023-06-15">POCI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-06-15to2023-06-15">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-06-15to2023-06-15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1'
ML#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,
MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@
M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^
M\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$
M%     @ 1C_45I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ 1C_45@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !&
M/]161=\FS.\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " !&/]16F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $8_U%:R3#$
M5 0  ($0   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " !&/]16GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"  #L$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="poci_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://poci.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="poci_8k.htm">poci_8k.htm</File>
    <File>poci-20230615.xsd</File>
    <File>poci-20230615_lab.xml</File>
    <File>poci-20230615_pre.xml</File>
    <File>poci_ex1001.htm</File>
    <File>poci_ex1002.htm</File>
    <File>poci_ex1003.htm</File>
    <File>poci_ex9901.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "poci_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "poci_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "poci-20230615_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "poci-20230615_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "poci-20230615.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "POCI",
   "nsuri": "http://poci.com/20230615",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "poci_8k.htm",
      "contextRef": "From2023-06-15to2023-06-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://poci.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "poci_8k.htm",
      "contextRef": "From2023-06-15to2023-06-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://poci.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001683168-23-004233-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-23-004233-xbrl.zip
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M3-EXZ0X\Y4IC'BSA0STC+((K*',N0>E&Z$D&I04T)"LX10)W*$;(. R^5"Z
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M:?-M2ILV((0Z#8+O3U8Q*E4,UDQY2QDC9G*IM>8=3XD;*O>)8UH6V[EC*DE
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M[H&O&[O!O9>V^,;]<N]>M5O^!U!+ P04    " !&/]16 3AZ,F\5   ^<P
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M32ZRX;QT%*J.S@\?1)O!@=@',.Q/'C_&I3GW=^'%=^\-@6>0Q#0-\<T!-:&
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M/FL^YL3RX&A(._YJ[V>5IV;DQ,A6];GV*WJZM5F*;3CYD7Z3E$4KH6=H7)-
M9?(#A@LX=O_:8/2L1J0-)BN^^R>6(%O!B.<X _CDNZQ=9/]*7G*ZCW0^^$JB
MH>/?7! 3;OB DF\(3YV,+$W>7[[\GQ=D.^.__J^$M;>VJI5DO[J9DCRAO;/.
M?M.PM*</L+3/ $M[^@!+^QV?N^ JZ3,B#QK"_0(O WCX^X6%T/[*&<8N^IFC
M'^NTBE>ED':E>14:*5"GE;>YECI&_)?C;NZGBG/ZMT6W23&SDAP@#_Z/2Z63
M'\,MH<(+D]N0!0RJ&33K<]7?'9T<>39>=[]ZDGJ$DG61WKZW<_WWK"G(XCM'
MS<F<OU\JGVJOL1I__T>4H"K>AZ5H?ZBNIFIIS-'_@S-('B6)F'#J5$][GI?9
MILV%#8%,R+S]DAA:B@&D;$&2K!(-FK104:&)]2]4X%-1I#%/7IBA;G.4FVA.
M8L5+3YPQ\"K'=T*:^%3R[*L<?2:=<-#CN_#K0RK88-G\Q+K::0:8D1A;($,R
M%32Q>>I>E'6-%"%7R=NCLZ-D.B-/33!:9 ZD\-;?OGSZ^& R3IX'F_O9EX^?
M).NQ)PZ9KP5FGK3\Q"GY/19%.\,C<WLP^84F%T<;]2=K W<#LHR,;!?H]L%D
M>*8CJRM^!;J5EKQ!VL10OOGF4693TV[!9!><%=7'Y#V:U;(/IL@!E+E(8]U<
M@=SYMX-$"B:81#P/'!VG</DN-Y7'C?-;\%ONU"%/_ZJFE$342I-9L9 M[?C<
MP_D_F'#7V]IU6KG;6,P@I042?##L$C9;*U7GLJ(14U=XXXG5P[TBG)@V$@ ,
MTL[7.<D7XG+)BI9 \F1ZLGI!E1OA1:!9]- L_#I'^U)4+E=S@!..%L5R_7"<
M)FOK"C8,UG2<Y^M.8PMD6+M;EP:;YYH["%V66GS"=T\7B+I1?33X,]^]__&:
MCUKTT==%?P>FR\G;T]]UZ<<G7/K15*8Y2MX+CY3E5$R3S5ID@91(0VT\K$<]
M6(1:J7A"-('G"/9ZMZ2UUI4MJJ*NU,#I+ILT+!,<E3+%A\EQ@W6C?933GS]3
M)3KI%8GVI7GE^?1@LED+ZXP/0^ 11@S6C\6*W?1_?'+T_$D",K&4VDT2I4Y.
MPW ?'SI7>"6B&+LILK P4VJ)=$'NAL$ S@9RFEXOI#%<(<8NTG"T0\PJ9R_-
MMM$+4JX=;.>]-[ HSHEW@-0QQ@1FGIXTDJ_#98V8R"9^H=:LA8,[-KM('4K2
MOZ *6$$0P#2O/Z")E3I<<@2.D@^X^[GP3>8*<_&FUXJ^81UVO CZ[VGI1?CD
MDZ.GJ7V%\E!QTA2_G=.['8PRRAI)5.7@P6D-,:T%)J=#+00N0%S*R=C+2"1.
M/96YI6469,F>&4!HA[R7[)?"TYO))CR8O')FS_")QG0TM&\D].I9W_M'/3"+
M]JQ&+Q?Q"BXM(LE466K)GW&6/^-)_)R3!+.4)27<I2#XUD4E8E7F!%58JN)
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M!?XU 741 JLE5M%3$<]E")W!IE?9CX3)]515#+0A1T&O'"!-Z$/)O\_^YOL
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M%&:@-"%KS[UV:U3,T%YJ/:\%121H-E*V&SDCF\\(Z&&YB7S52XN!QT),=)V
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M.'[FLD(@15!.% )<E!H3UE[*6E6J< Q2ZL9>V#0JK>8Y$$&!/9CQ'>$2$82
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M9_.P6G'A*O)FON=R7F=E5BF&]Y0, %OLZPJ3HOK[>IP\JE\J[!:VMS:#VL2
MM.!+'KE?(JFTHUD'QQ/R&B5S4C<(B ;,?.K0T^?1!:#%ZG$*O86!HU<X9A9$
M2<M9JO;]MYJ0AA=2057;W AY9EP)I5 &8D'LX?F]WX2"L8!#-_B"^4=*=AL6
MG*@Q@XB ^T1>XZQ0IX,K)Z 6#]$F$/H[%] 9FQHX@Z[!@PFUF :]0W6@(.=5
M&M83]/V8UYSZQIXG[A;Q' ;-X(JFHG5QKIO'? MVLZIJN.YS!3?;S!];=&B(
M@ ?OUMCT=;G=037;3=FI0L(WW;[)BZHB>?&>4G<(XLPH<6(NQ]Q>J6['KIA[
M)@M6IC#D#AL/?V6*/VH)1R'TMV4F77CE[CR"@%?2^HGP,?()M5FE)=;$0+25
MCWHSD?!$H,"2<([Q+UTV5%=[BYR06<.4SE.?//S^]<G+H,K1?NVNWSA:Y\D#
M6N=SH'6>/*!U?L<G;UK7=*.0>#S/V7]!]8P/)M_5Y8(KICJ2T#Z(V14E$"KC
M'*/G;+6RS*6"R:Y(\K6T:1E,AY/_!)QS,/GKW_ZB0EP+ND)/;W+D.WY9+W+F
MX?_KGX>]^V$U@;;60G+)9HVZ=@^%)#ZF7UST_\:0F=/UFM;]!1;=\0OMJQO<
MK4$,12S@*U,=W>>8JWHQ]#I?#>)YL(8'DRG^Q%_/+[Y[>6*O9PT'>]^%:@6.
M2/A;\J.:*NH:)A*C,[G@4K31FZ*G IU@=V+EW9-2WU:M@9OLH"Q:HAL<CLV<
MU)3G?SIT(! UR@*F%F3><6DR\S)C^HF;NG,\+H6F#':WT.3V4?""L&V85W(]
M,RB#""6U/A,VSRYI#8>A218N,ZS4^.I$L_MS=YF:F>QCY5DM&3&X+/FR(DB/
M^+:EQ"V9$12.EDG;,;[>+K[/\!#LR./;+UUN^J]_D63YGIATWF9D2"O3&!>W
MZ3D]=]>L)*[N:F$<HMX%BDYND.N,;AH*07ISWUJ2Z.UX)!$W]OWZ,I5#-;Q?
MDHDRYPZJI7%I$7'G[O=.G/WE<70E^;XPS5#I)H>H03:=4FW<6=S;QJF5Y09A
M@W$)UW@1,-O.\B(=:MR+4+<,9#ESH3:*52,[$@,=V4.Z:>CLA#P@5S@YJ66>
M0$ZEA3/X-.C'8;JZO!GP 42&82\]#A\?' ]7MV8I:$S93TEF]_'+?3NM36.2
M-=$QYRJ,'$Q.;W*7/_R/@4RI'H6=<D900!^#7'Z;$O64G$PLZ\/4#G\>I79(
M-1@;P%U3>R>LX57$F5LW;1K .C$V@H#D)O9:<"UX"B^K_X+=6/)GO%4(&$MY
MI'0<E"U*J?S<\/@],]A G-7/Q/#8VI/'?XJOUMC'8F]QN:[EWK4@7K 5YQM)
ML!-W*#.Q^$M^7=]B5_3JY/@EBHA,.;S[981I(9X]?CZZ$(>*@++EVIVF*!!8
MEVHH\1_"9J(;$0/#!&.Q5<20IXV6!]KA.M8,&K.$;3 ?>)*OB(DLO>N7@4RC
M!//(E213+\V\R!8XM+K1MRVBO8]3U,Z;8F8F"7;K='$X/3XD/&&-04KT=H_6
MC)IF!Q/?[?AT)72X0E$L$ _"QO>.(__ 5OZVO7I"RB'^Z^EAS_>,G&JL(RU\
MCC2BYA@]XGB8'/$;_FYPGB-E:*R7?>\WW\MP"SI1#L*(<';NJF-L/IUL0_?>
M2U'VP\X/?0D=SPH_0$D#;U\[,B3?=BO5-Q::"$GM[]L%T+;L4J:%'SA5416W
MZX$*M $,3/P!MUGC@*M"#6()$T=WF&#L7 BD=F5J,2VD6, >'S27#F%GKS:5
M*)86;>K0 FN3,SV<1VO1MON+Z.PZ40DZ<:WOU@SL4=<"C.A@B4^A%E$)=P\N
MQ6U3,"I PU6\HR25YI7$$::2PS+2FP =."[ 7)22S#SZH>?K3?U66(/]G(GN
M"-.:NF(X8X)97^^H' ;?OY=IP,BZ3X'^'FWTP>0?GC>ZERPG)62"U)Z4CC9<
M$GFY9*QDW5 * ,D6\YAD9YO<<T-3W4;TMP<3Y;]%Z\N;?78+AA$R?&H)EE<-
M]L=T4Y4$Z!%/@N:>,;-N9^ID"&M'QE4JU2LY4])M[$CFZ\SASP^_W#/ID_%U
MU%QEE617?)6<J%TI%])%+^%,/$A996!;;.BI+V>QX41 I<<B> Y#F%)$'A0+
M0R?#CHB*0;Y..?>J'L*G'*U9#&<O"(%E/=SR)I-OAMQ;'!A)/6-72O:&5)1*
M.441^JF4P5LM76O9;$GG%Z^!L[XCG!Y[JJ@N^VJEH?Z?45C) PDH1:9!UHT-
MEB;".3'ZFK?^',J!52RZ,\06$YF\ .,0!.7NG"F&DS*/#5F2LU[RH;I&?^+P
MO(^)]HM,Z;^%4#6H0'?O94/.C=ZZ:?VZK U48+'LL$$G!MS@1!8.]3SF=I4$
M3*]'X7#(#I@K>#]LFU5I*@<C2S'TU&ZLD!;[)"W I,5UG E8L&.  -_8F5DA
M/ANW9?I#1AX_6.TYE[M43'?1#74$SQUUQ%E2I#*T;D5@.$I]208VMDDT^Q68
M^.IF,[XW] @CM>*<"CF!.GG#;BX8I1%/*1KWZ-HJ-BM_/%S%/4>V:?,/7#TL
M&9V#S3!'9FUJ+7#].VFE5.[!<%3T+JO_$%#U)H.=-G/@7W<KF0.4.I@NT<X@
MCQL!.*0BIDX2ZM;0K]QR[N*$+'$CMT2@LJJ\0B3%PSRTW!0 P*3566X['R&R
M]NNZ^XUC+IX^8"X^!^;BZ0/FXG=\\J9<MN/];94(&2(;.JC56F(L2PXPEJ8O
M#D;,F&\*\M%ZG[%QI;)>X[#[AGMSS'W).+XJ+.Y"&<HFE(STK*0IMUQ,UY$+
MV%X2"A5OV*Q4VPW=X\IL* $HX4/,DIL"YANN,-:9#R8^1XES<]":X_@N:0H7
M06!;??:L;%*-BS!C9,!/>[]QIISMA5ER4@&"2F=KNT$OQ>$<]^\7Z0OF5MUZ
MN$TMP0WK#$O(QO5A;K^/J(R0JRUJ29M;80:6[$[)I#%@W2A53%#8O_3H:$=-
MB3DEJB)JC'=*LV,-@MDD HW1(WFH*"+68\PQ0AQV9[UIL-ZO"V6=VVI(%[[2
MHT5-[PPO'TRDS ,'OP;&U1[R$8^9#4?.31 ZHZA3OS@,,1U(.M&>*4Y3KN'A
MY])4\CB8G)@P5&3!W(YRVQ/=TVTFN:##]9'(NM(4L2_%)[F#XMY1P63]J-OS
MQ\?3# -*H--G&,+A_SZ5__Z%0SKPK[_NB#+56H=+.R&^27H/&V"<P3C;;/.=
MW3E^]NP$O2^C9/OQ[NU[V()ZR=&\1X >?.7!A*-7</K8-#\3'J*IZ=XL+^O;
M0[9I98BS#)ER3/AN9_D >@/&0C?E5=:-7'F$>>-B4_<H-&5;MGW?.K8L\NMA
M7] 29\\STI6Q*\K$\(:"DG3G!2YF1X9DV<UM)P;E[;Y)!*['<?HC,AOE4LH]
MTJF\HA6X&,1Y6 K1DH:=O5LA(O/D>@6TP4V"1%NOK]%]:*S@W'<&:_4&J9\>
MC[3*.DJU;6O)/.1R4%Q";.DX2>6.6$&+X@IKBO:C$U.:%(.F/(N?E<17(C''
MWD(:0:V-BS <:IN&Z1L<O,2PI]3OC ]6#N9_O2KFU(KP#_?Z9-EE.-XO.JYJ
M6!QX,>UGRR52)62.H" IZW:PDWNV];DBR(XZ-/TU0QW*T ;VM?9,&8\D(*HY
M\B(*"1E3<MUHBA,.<QP$6F2PXI0Y1B%[ 9%4^6V[SM9X(E?95?;O@D^C>DS1
M Y41L*RIL\6<* ()UYF7N4I%T%JS15$;;G;!"!+_$I80;P)*BP CUG>(.CJ&
M@4HZ!(*+"NGD^[CW7,$)%&P=EIEUL8[AS=<G7"LXX'^="97S&K&4L(<XE-'D
M;!...NTMU0@5@J"4<Q9CK93!;(66O*L/72C:E+8(\RY9SDAZ[$"/,A!JM%LH
M5X"#F:V.0N@&?:" .;4$+4QD(2B!VUNJ)@!Z2=HG_ Y1:)*6[LK<D[-=G*R+
M(@#2[J@RJZ/V,OY@XH2\L$\HSZK]X5>B8+H%MAF=V0PC/T,07G^]N5ZF/H=S
M:4# J;\8TX IP:"UA4=$^ W:#57/D;A'SG"F@O^0^TRB<'HA?&4\UP,+6L^P
M4I"8DMF"NQLEK\8\Y4A-B>7O<JG"4XDMESN.T4UET%8Y[BDFK>7"0PY=[G<*
M]&25?:3MX?D5S+WI&-&'>.MW7-&[*@T$19DC<(:OS7P29W3&, XJ'ZAHJMCD
M4H^#G4YB_"&&_*'!F'U;H49<M'K%#[5@SAK7 VXP _O=^,"2_KAL24=<!*8;
M";T09#=%. #.5$Y(7_?D?@/G+NZ"U@GP7?!4J',I>U/5U2/)L#8CEXJ@T90Y
M#(ZO01CQ!N-6RQ=*B^JQ;\BH*+2+;X:!48BFS42EC@TG]+!$-^>.+17;@2:1
M@]B.&=5_CSH/O=?NV[W+579>2JV]RZ#( U/?54LJY5#0SF33QT#Y'![ W2L[
M*QT(SCG:5XZ:,Z"K)H.7"37CRH9L8#O?F^.N<" +VG/QAAK&_"4NG$WBV)-8
M"H-3ZHF?00GQ),\IKUH]4FC<G:0^6R[JMF#-22T2395R1+31Y"P+&)8A"*.;
M&RX9KG^,J+>.$8XU*)&'G@XL)BQB:!-[$9Q BC,HVKSKA)Y&#JVO8FJ8/'95
M PGQ&I)14:Q(\>Z0E#K YWG\!OO&D$LC)%O'IS"2=%43NB\BZ\S\3*%NE@EN
M804*0O&(K_[@\KO)K]'@8 8\1"9@#C\Q:L.(EZ"9UZ(P$#4R_B-\1-6D$7=Q
M)KP!*JX'6I4@BKK<>PDF S=U&U33&^LIG1+VQDM'"0RPLZ?*QQ%XR7WU-E#,
M;G+Q0U&I3BHW.WC7RCMI39A%0F=_MA6ZT[C?O-UI:",##XA=HQLQ\']9!UL@
MG[HZV/F(UB9(2[\$#._)L3! [+JY@PR>PE-2&C=UJ2.M!_F NLJ<A1[K(1=4
MZVDPVE1+]N!3_I(;%* KY##,N!#R-9'86,%-ZP*K:(#K-/-T\Q9#'+4\/^:@
M6PN)CRZ&__ ^I]WNQ4/XL\,[CS1%Z!AL4A<+U1 6]69&5P)7;D 9PZ.3(@V\
M*P/>[&@?(^I;@CVI&/-4F(\=$4J9WTL1P[+:&B><U4U#+#>:&8L%:9L%4P[G
M7#$M(O[?52&>6?SW3,?XC:-3GCV@4SX'.N79 SKE=W'R_O#-I?7;[/(1]%4-
MT1TS#2'2W2&<'5A/QY3@6-4+>%O*B=!<+H6D[UUQ^X:+M%DM=_!6=Q;/K<\E
MZ/<M4!?ZIGV0'M!KP:OA0Q[(--#4#R8+!>62M=)V#?]EK!4FTW8XV[$K/%1Q
M6#40F^T>!>HXJ0'K,-Y]BR>_\B5.<**[;_'D/W*)_V<.UZ_Z%B? 7WQS<G[Y
MYB5<56_^?O3UBW-XV?O+[T[/DY-OST]/OS]]=WF1O'^=P$?)&3YY>O'U%R^^
M^95[]?GTAF='Q^@5H5.ZQ&11 <85FLVX7VH4XCDN0^,+G8QH$&(% +0IF)Z6
MH7(QO(EA3!2L%G!3!&DZ2@8<AGBZ.UV VM; -;4[G!=(\N7D-#,.W6"Q6HO%
M4IQ*3%<H%B"T$OBI,YL7T@Q)V2Q92QWSV!<"#^MM!GMJ.CL,TUQQ%H4HQ MA
M&"]+4H(*H0',+M9>ZECE"I0CY+_>5&V.4UM2EKVK$&':9/X/7]UZCND-&A4W
M3:<JVCD3H=W,4.:S0&>_L+[899Z99K% 2KLD9 V:V1'S@KI]M-BT^KO<4B_J
MG,/*.C'!0JH_0Q_'>\_LC''4T8D2^W!4AJX]:8-CM$&SN3H]2'TQV:6"JYC!
M;#OD36CYAC5EN15R^9#V0WD8K&?8'*=HF^DP J_&GLF<&<L<F_M+:Z$[JE@A
M(%AXP&LI4D@L+K)QO&?(',&4IQJ9X"O'GM^/MNA-3ZF9X@]=?<8<RO^0(O_=
MFPL,9W\X?W/YS^2[DXODW?O+Y,7IZ;OD_/3;-Q>7I^>GKY)_O+G\#C6!@XD\
M"MI <O+N57+Z?U]^=_+N6S!WWW___9N+BS?OWR7OSTEI,$_:+U_#[_X)8SFY
M!,4#7_+VS<F[EZ?)AS/X]N0=M'CZ_=DE/OKZ_/WWTHGS$_KDP[M7I^?]?KR\
MQ&:/__;T:9K  $Y =WD%G9YB+P0B%S[NB3-@#/!_+U^^/T=#_>T_T^3[DW_*
M%$"CKVGT,*"+]V]IL*=GE\G9A_.+#R?O+I/+]P<3[#$\]O+RS=]/P\[2$%&-
M\MU.XEZ?V\9P]"=_/WGSEOP'X3RD^"Q,UTD"S;^[@!_C-]C/BP\O_AM>?S"Y
M?)_2.X).G)_^SX<WYZ$V%W4"EQ%;IDF@I:#5/CD[>_OF)76%%\O\[.W)/Y 3
M-]@Z.&\O8&'.WIZ^^O:4FGSY_MV[4^XI-YF\>/_N)'G]YM4I/'[^K;SU XQ>
MOC=;[L7Y^_]S>O[HU>G)6Y@\&#TKIV_?G[C67K]Y!_U]<_(67G9Q^>;R [WJ
M\KL3F(TWN#]U]>$MT.2;2^K6WT\O+M^?*S 2]LNK4VB(>WS^ 8;+Z-J=JV;Z
M0E]B?V%3?WCYG7GX5Y;>GU-2[S+_X:8S]K^]XE#UX5 5Q;UJ_J_H44%L#R[;
M"N.XBURZR!<!7;&B?IE,E%E3?\R;1XL<+#G2UXB,'.]^5SE/BT.BE&^1C0%5
MH[(<N ;H]3Z";*#0#G9Q']QVXH'(Q'5D<-OCD&R",A9+?YOY)YW"P4 3GZ?1
MBPO@+#O-:BW%AFNIC(>]"0=+41IZ2JQ@?BR1RJZ""''J;MWXQGVMJ%D>D/OX
MTCL]@$]5<QHOF/5>D>6HB*JSBDKE3J5!CYC''K^I&ZN)RGR%BCKIT[A=CI+7
M7#85O1(*.Z1?DRWC?J[3RZ\&!9+]5S0>T#S0..A[G024$VKYE,@L;AN;I<[M
M&W"/>GP\2D2G.H]78QN91&Q).!U<^&=W&BMV]7I;WP:X8,_VX2A-L,J!CFY/
MKU>]G@TAX06G2_%513MSV3+%B[KU4-S6AHA"US (D@"&S>G9DV>@-4Z?[LYS
MD%B;SQX*X/ #O]%-S(N.=A-Y( F(BM79:*=H,IDI2<M;[G.S0>UCV&<?WWRO
M4-?SAU#7YPAU/7\(=?V.3Q[F$+XD.GC,5D J:?36$;R+/147''3PH2R)@M#]
M)IZ("%HAGWH@3L^1*'"I0RY,?7M=E+E3A&.GY\$D:GXX3_60(37ZD"\;S:62
MG/K<&B_K./$JP;V] X5X/H,&95JLMJ">68=V-7R W365B^MYERF@Q;5?DC[(
M-5:?.6&0G+]"0!+V!O4:T,ZN"N)Z%@B@THT0&:U1.*@91?_PE#G29Q<.,P6Z
MXP*K@L#]]!'P'+4.KZ2=KQ:N.S=UN5D)#!D4P.91O7Q$8VE,+$.J<=\<DHI'
M3<G.*P(?K+Y[K SOL.)D-MT/\!\QH4",@L9GPZ6@6_FR3RVBM-N-SVN$7;Q<
M&NMA!5\SJL@:GA)'I$+KB+U2^P'!3=@<^_S0#!%+0ZP=%^)A6+&LF8$48LKG
M&E&BV;*3G7[J=C\QNED;S;)"^59]E)$WR<H:1#+A!AR+08:EJO""G\LLCE7"
MG,35?92\D<GG/3"^57^Y0X458@?WI/;]?OWY&2?'%%'_14X.=WO@ /B\_=&C
MX&;CES\+R?V. ME1FG<2W#:S7)M82FE5_)2'V/XJ)TC/"VS9_]"!<><EL'ZE
M]>#DA .VGBE_3PWT%]U#&J5")Y4F[=J=0O&'O.E[:WSXX6""-_?\D D""JPZ
MC+_+.LN*FV=-6;!!3EECMW6"K,R7F)!(%));QY[%*4C59C7CYX-G\*@TA<_)
M1,P&5C.YR+NN%*7@C-'H VGRX70X4CVDV3+.I>$4EEBB8KAE[M6C$'K.F]6)
M?.?.DROJQJWVU%%9QL4)WO(#Y[))<,5"/FSUME!ZU:;54N<>-]-#_5*D<*S+
MK SQ(5,G(!TN\F;B&;+=-TQN0X<.I2.!F[*/C&>!/R3063$3(E>9( EUQ3G9
MB 020,KP$:1>Y56)Y<U5DW-7/D&A]/E OXQ#94>!5GLP0;%LI)KQ_L@:Z3GU
M)],)(7KC"C,5=ASYX.;%Q]B?JMM0F'X<86;?^P8['HXG>X#]/?8J7]=M0='H
MRP84>3?Y4K4'MS_ALX>H"C%PC%6%%;#DR!OT1*$+58]4PB=*O;Y(W-"JX.;C
MU_IG.1<D-;6#T2(8.<_I&((-AYS1R#).4/F>BZ".I';Y6JA$N*=2UA1&)="6
M8=&\\_ FHV>7$.ZP,8["0*[L"H=JL)Y226:I'&ETYG:5NC2#(DLOOCF7CYEG
M&E%)OK"3E(H%/6%(C+HTE)@TE'N-P (<H!W_OL7@%X<NGT_3655:&CH,7X*"
M7:O,&&GX'D-WN"Q_QCG05J]%%2]KKU-EW*2P RQ]6<"E2@5Q88NN,H66$D,\
MP3K6>965"/)'&85U(I(_'J>/'S\F)SGOTNDL(X02[_2__^/DS"I20R6">\Q;
MXO,6,1;)WH,)R;%#<Z\LB?XJT%T&;C9!V*@LM58^Z@I_/'Z,HL)N75(F4=T1
M/,H?GP2/'$SP&:K*-7T>JPZDD\E=RC,I7+57&UI:#&)M\D,_D?:]7J,;N'23
M*1=T98T&EV*#(%;_5G8\V-/*U-2@*G5%R9VRLH8JC.A<JJV0V6F;B@%O=]<2
M-A]=C!A<$\45XY"J!4S'U(##:#OJ/34TU!U",=+]VSI0- (PU  Q[D]0*'@F
M9C01NQ<H5G)\JN.4G%&83%]I%6V;]V/YRPY-B;C@Y'A!2G%5!8%I2A@[4H:8
MEN$ EZ6CW?-99*%V._Q6QDS[B@MW_L"7#>^_U&D6=S8RE*:)@&^J\4/E43!9
MDW!#<3:FV\@4VXJE 5MRQ*V39"LB-@SJG",C<;LK_Y +[KF4.:Z9;HQ/5H[0
M1SMW]J.AXT8&;O04K6&4>8=,SQ3/;"D2#5T^=,;YR,RT/E]O\9/?F_1>VZ_B
MN-D^@EOIK*%+WU1S=$7Z0+_ ZFYD29T<\GSYA;TP"GRP/)G!CYDMW;_U=LD'
MRCZE2C7XU/0%FVI@4J'LFTLY -JTO$ C-Q%VR,I?GTD,A[>72API<;'E%DN:
MR'A;:G1;'7S&IZA5T<(7\'RX5Y#W(MN:H"P9%/.2A"V*ZKV,@B*I4EQ[HL7R
MMLQ>KGK,#W5!M<N=U1)5HJ!,4/)7Q-6S!H4100Z(L3(L0A-XVSV] IJ9)B)P
MMS_+P -B,DX?I_?;SS:8:D&%'_/5VD,SB,)&\Z;Q$ESV5"]T(8;(H.$X!@G1
MK1;\X=^-^#C79181KW+Z,UF[_ Q;?93*U&,<&O!.#6AX= ?,;80H-*,"OJR>
M24X8'54)J4@A6L5SYB!<CR8VR4CEB:(-^1'VS)#YC8?E__P0EO\<8?D_/X3E
M?\<G[QF7BWK-)?T$4698Y;Y"78Y"1C'5W'Y)*+237W.(@[QE%'/8YEG3VA".
MK6$5NG,0,U!1,2SB'6,."KD*P\2=GHK+:J)>;\=/T(J%GL _KAP9[>F/H-)4
M5SE1ZRH!'H9A2O1QE.1V$.(U+@;9:JJF\WZ:HEST"\/S:_26JR:;*T//H9C=
M3.IG[0$L((B-.#>VBR:YJ;)$SS%!N(Z&8H)8-RYV7TC8D>*R4;WPX=K2SFBU
M3>_;%H9]<\(F-07H=MM)SB1OBQ^3Z9\/L8PVY1M6J*P*UV)O)8T=% 0#&=@^
MB!Z/V8EL*/SGQKY=,'LZ1^[OJ*"6MFX"/WBP/$$-.7]ZL)LTWHWHAV5W+;K5
MN*1LI4!CLHG)S;.])X0E!NQR]RFIFUQYR&*#II'09U92?GF@BB[^LM JNICA
M36456_.;(%<[[6$?S*C\,-#\V)H<P4 7M^]]<IA,,^.-Z%\DR6MH&MX<^";(
MMT-AGLB9WG?DP*1\NC.=]N*0/_V^OO3$N-)GNLXD85R&)-ATV983Z.'[Q2:H
M5Z=UHH;+)5#Q9O%J2=>\=PM)L^&LHD*73(^/'O_)W0#9U172_V)50RRV#CN!
MS<83;FG<%V:/HKHNMGHJQQ:,3U)%^Y#2!S'S 7; ].GCKR\^G'W377_]!?[W
MD'S;R13,W80+ >+I8&DC;CB4%5314:+[!<+VT2%^R'<27QGL_8YC_]EA%(<8
M[S'16G)F@+J"(_'$>0S]8SF,7& 19'<2[2T-UQIL3RQ#"%@GO @8\A-W4.O+
MRF6],"!(-[2#.[Q2P]LRB$:3;I!1-K!D_<(SPB$!^S8^B@>3H:4]D_Z0EB>G
MDGN[8S_HCWQ_J8!P/8S70#<?*E&\TP2AE)4YAG_EHI';*2#8O/OM./:B(AEK
M@A_8/&XL^/,I;<]F(=LS>:$L\:^R (S#U6J1!%-><<6>ZD8J,7)H_>X.Z:;S
ME)^^]<& #'/2WJMI#(2+CL?HQ=3F_ >$BJ@)S%U9;I\JAIP$5((&[Q-?D1RO
MZOP*,Y]V= 3OH7K.<YW>?XET@V2-3S%3)Y'X3(^/GO^)8G6\%5!Z-$RR0M)#
M9#1]V6I@C+8;3 D6^R02%C)F OX4NMCO9,*AXX4XB@YEKDI_U3AV')Q4@I2!
MBW$HL]V^A11HK??G;C$FFT-;([L5-@6J#[@=(-3#]!K/J)<A*:" V(:*$"H?
M3J\4X9XIP\^.GJ+=^P9VX%7CC5K$8!Q,0K4!+WV\IU,F_/9X9U_VG+_A<A*;
M;5C)J,JOZHX2X8RUI;J"HL4MNLR#V \F3X8=RU*XG;,)2?/E82C A%SCU%G7
MUZ'D_4SDAFW-$FU8T_1@,IXN)MRNP^^IFU^@LTM3*\;9<LU&ZXA"1S>E(8DP
M$2%!^O!=+_SWX4@I1L?9:#X/,V!?U5B4*E%"/66#OU*5>K MN /8]";H(+JS
M!EM% A'RK@5AY;T[E\_P7)JE?XOU5E\Y/D[GD'(TRY<]11_U0G$\^!]2!U.'
MTB4X&<J^'"/ PO?IRK[<R>8[2/Z5.M5RR8DF+\78X\('J V]1KJ8OS[Z/S8T
MY  R_1+,K2^PT'%%A30(;4F,6)PUK$B11AM#AP._1_*:,!,8K'$*CV4=9TW8
M3E!H3MDJ5!$@D4,^H&QW]NICK1KT%)EG5,[*TDUS.L*]'J)/30#6O"YR, 6$
MYVP*%8LB:\BP\E_"3XK&9 @,L] Z@EGZY95J74.D[;M*8/.R#*XP<3JIG9O:
MC"&-67W*NNRD%:34(OJ0J>1"VEO/Y68)=Y2@>NO)!%*G)D:<VF +Y]TMNB1,
MEU)+/V\7PY6\O/=B\/Q'BV(8[66^T$*^Y@)'POG?WS/1JP\F \W0$+DAWL@H
M"HH*X8TA/AX]7MF SD?T@:5@3.D);K-@YXNK74D?TJ)B?)E6M1T$INZFC%?I
M8\L!:!^U#$#<105^;0=V%I>C\&J,PUY;,]D3AEE/'=^=.'Z!M@<;(AX:08L"
M82PWN'?1T&;9^88\P@[<ZR5AM\C0U":]YF?JBC"-&S9]G9<++G]19MM\X6J@
M:W:,IX^.F9:PNBD19?'K,B'L-O</\Q8X]"^G55D8L&@?_!P-E*?#PX&'EZB.
MRD7=2579]Z!Q':M(EK-XJ[+5P,JQ\<)$E*-/*>FG4!H,W6_.I4IZ'H+441S,
M27!%H.YT8*>HJ#([)JYZH%7L,\+4VB4;IN,;N@BX0N4VPHGX%8CNA62 "<WY
M*SR_ S*KE",*PM!<J0ZB.$J*]W3WV)AF,E5M-HKUT+:-_*MFDQIIRTEH@WO4
M=&>-XK6S)2,-+&KV.5%1^_7F>T$Q_O( Q?@<4(R_/$ Q?L<G[]G1<S)]C0OA
M7(@PS\I,_%.P$T H%BN'V],R6CF:3?-^Q+UNC,4XII/%E6]29S($=2P)<.V#
M"">NG#;_RD3QC.6 EUY3E^P:X6I;K9@[KD0KZ"4SU*WITW5=8-QTC0.<A@!*
M"T!4AU0F=*'>1#FTY@P"SA]UH+R2BYN1C$U0M=TD>'&=93:*LT6][GKSF3I_
M5C Y2&@K[BTI24C!H.+JRN.L;Z1(C8T3#O2'8HHW1=-MZ)[T(/E! M=!M8#T
M9;\"$B-U>L: G>8BO_[>WK,;]]G1G_'TO:NK1R. IX/)*>N(0\99Y#$:+ABY
MRTDPOIIJFVC@A$I6BQ=EA$2,34%1:3G!*N3?)ZD1 HN>'AV#_CJ&6AHI9(B.
MGM27F3,B)/$%R=#VEZ)D)+543PS%"UH*=(H93]VXU/K!BH;4"4^(W[*-&#JI
M7*;[#",<-UQGP/W +]FP\RE5GZZX@MG]MB.^(\(5W8$.BP1G=^W-C:"8IT[H
M(NECU>OD8YZO^S^R;IO0#>%QRV[S+0O8B5+M:]!#03Q^Y=8D+3CCSZV\EXYD
M($8\_Z/EW*!SFHK3:;)UF-4EKCTN8G>G(S!*.E,+;R26)RL1[F6I9.:VM#C#
MS)X>7%HT>;E.)!6I8TK!V'T6$X./.+UV>2 QJO'I7B_)[*)^W;,3]_*"HHRY
MM^>-H'B$?4!5A'?2+&LQ[+&4P/!="YR:"IF:,F N5UZ*)D?@9$2;J<!$L%^'
M-IW2!:#5Z5X1%T4<$KNAK&!O$\9P<&[NW*Y!(>[8-QWNB+X9#9K+IH23G->;
M5N&;G)?%PU!Q07%*-?K#C(_QN,/]I$;R"4*#@O*_D-38-Y7C+ZAR?&!OY%E3
MS^$V:$77Z$>U-N)TJ7+BCZ&'#4QS.'#J6290#= :ZO.Z61.D@LFPZN8CK5ZV
M+B0OD@*MG!)L7*%MKHYB?ON7Y"Y3:$23+S17253<,%.O"?\^!4/@!C$_*%HH
M9J8YDY[]0=H!4:\^2D0[=!*?(%JN^2%NJ9NB+AV"^O7+LQ/\[OWKDY?6@_4?
MJ47SV]MD?V6@ RQ.Q:E5/$TF29/W' HFBZ0.398(:?;7 ?+>0M[!U@2:L+$(
MT7KEYG(Q5XX)GJ-ZEF,6JJT%:2X@OKI)4YRZ.(_1/ELEVE@2R@7KBV,)6[?E
M$K!(M6P)JZOX7B6N 4T%H79TLP4.\BPA;Y7J<_146#F6/@(MF@?.3=]>UVH%
MM[&2,34P>V1"$9^O X </Q^ARL)1ZW(\>1SG 1!(Q.-YA^8[":=;+_G>M"=8
M=M+/_*\PW<DGS+:/&YKI=H_(+)/G?"T]F^)2(##*HA]U^L\PB!*@CV%25J3V
M,Z^ F,8$'Z,2]&D"6@\!> NV.GRX-&77#/ZWIJ1%A-+C+P1$AI^W8DN9W&WO
MX8"7_+!97(G5QQC@UB';O%RDEC9-Y]O#D(,CR,XZ6.HJW[:B$"=+/3+\/"J%
M1+VN<M0I2M'FI-DA]J5VHP =0E<R"!H41PQPUDM&.:.4)3)/9I4@H&'#@<^E
M#<1&MFAJ"L&EQN*LC<LBK.SKLD"&JLT5)GX+M^A@U 3OC1GW4+Y3SGH$)ERA
MEA>IH#05BII"PSA;9XA B33ZE=![A5JU4=>IWA#-M*? CI0@$A>2X!(761I:
MG^%@Y]V0E5TNAV2J>"9BLI\K#KJ%8XSV-/$6$$0A\V:T7^RA;HY5$X0I,84
M2<_6'7"'ETNGWNP2=7NI".F)6[^CR:9SK@66^L&B<.-.L6@'V '.E&*>:W<A
M6GBX=)>VABXA9%L8:XH</814IZ ?3+72(&*\-6<( CL733' 99-M%FERU8"
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MSBG5X-N-,BS#IC>6H9%.X$/.XG,I093'=:1*%BE]RA&?P\7%G\[/<GMVL*J
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M=V" R3B4-T2%?G"B725%A,"42@F<QXFP'V(ODASB+V^&5^&0?9<<K1[;/3G
M":VL.,E+].3:H9-A+<J 6PU4S8HB;DKIT!%)O+LQ2YQYT:]D-,QZ(B49$@$O
M5X@(^K3'U7_PK:I2$=V/K+'@#/=$IR =.K.VGP6SIR'FQSP_];15K%53;B9:
M+L&T\3RR H$A;2/Z>!6JNM.J'*MONR,F.,'4IKOP?"5FD2, >3<5!J"PUV 3
MQ/V^^H$JSN0_>WF>9Y)$A'C>@X^' 7WG')#/L%#[16*[SJ%Q]>""<)F_',Y>
M"%@7P,/Y#J^V$]'ERH3?ZE9:7B*^;X/MNYQW4<B9<.6W$UB,A^A*YZIM&BV@
M*XN;MUO"$?#\(\WB=GL?;AGI9'2#:/4W \=<=LU%L:+5Y+!!D?$JE_TYC"Q3
MW"$5( H#MU%4HU)!I"&$["(<4GTOI2JS2\QC8G;$W^C$(SV(7V1_]UGK&G-6
MIW*J8\1J)#2>^JHSVTZLI;JE8 S239591NP52TI@O@KB[8EZGTU17ZX\1NB9
M_#@AS INOTPY414^Q+A,;Q'TF9%XE(1,%32J2OK VVB4W<WI0ZC0S,X1R?E6
M^_;UE#,UD_S&A>9B/EYD%BW4<!/:A3G&1(.QI.H1LE79DX@T9B2W=0"3EP$G
M*;Z.<BIGAG0*Q91RXN#E 8+1K'ET&\J5:C+A-8X*-A]B_S*,I'SI55"1?5.1
MZ%3 9*IND;.VAP&?B(^5RK2VDX>9JYMK:+.18H].$2G9*'<6L_:3U>22VLV6
MSZKI%+2M)#;_]8,I=ZBR;=5U7#3R; 4V?3!L*#-3U@IG,7<CME=MIBA!;$Q_
MF4E?[)6S@/47).KW;,H*8<KECOD@ V)-)E<<O/+9YZQI1C!3@]U47)/CHV:U
MKHD%#1AW;49-*^^\<#)3H&?>:>BI'#!=&F?^W,0O:,R_5"%D^&X^=?Q;:@54
MP_/BI+PN>VS.453M&D7U'"BJ=HVB>L$G;UUQ1X=P;9 GP=EACYW%,EM1GLG4
M);/<[TR^0+2X\Q<J%Z#F7/*$VH'I9&YQ,7))C#S!'R["$MK$%/RY+I<367/I
M(XJT1^2QN*&7.6!7=3-'"-%OH\K2/U[/<%$9/GNRM*48LNF$8K23AJ3?=<K0
M#/!'[ 6 *6=>?J.,"C/@4A#E66WY9]K+E#]V@I:[[XWQC;"Y\!_+2]]0T--G
M0=83)[U0BR-A24R5#M!TH]G/;6&P*0U64D]CK=DU- P3*S^&L?:F#J8<^#9J
M7TP-S_FL"E@3(5,>NY6&%)\S&;;*?N!&<H@=N0PUFPIQ8U'F(YL=9@NO;D.T
M"2*Z;>0'&HFS%6$+(WY"U95^XY6V\DIM X>M+O'9H3,-H65#)-4812$3?. C
M4@:F4L*1&\/5D4I!.$7H;ADXR6@02.Y?3HBK7).*35J @M[E67@^$J()3KIG
M9T\\(*^B4>[;3[Q^EN<SB B1;2DI<3J6<I^\23&9-;F&YFFU@F)B1Y(G@()8
MXI^6L#\E[7&)<UTH).$<2*N$>ZA)S<H6A?9(&+E7F-(FE7KZ9!\120CGSL7)
M-29>IO3B=#@ JY9H@O%//Z0 L)^Z\CT8LV?"[&W>& J#8CE5\CLJ[S@M&;E<
M#>HZQ:GVJJL"P9EM.;]__@3']F=W[\_=8^?PB_/'C^-_PID]WNONL^A&7^V!
MTSWXI]/=/MT[/(!F?^R=NL[AL7-T?+B]NXLJO"./P*_W3G;VZ$'G\_'ACZ_?
M3IW/_Z3OCKK'I_"OK]V]@Y-3^N3P]!LT2I_#F+[MTC_W=D^<W>[V-^<?!X<_
MX=7[T)WNP0ZT<+I[@._M[N_CXX?TBZ_'N]W377C?[O_%KYVCW>/O>Z>GNSO4
MZM'1_MXVF1O[W9^N ZWMXL>?3P[W?YSNXFM^'&P?'NSLY>_=.S[>_?,0?X2]
MWH'W'AWOGIS 7S1')\M+7P[A">@WS1$V@U/6D&(H3U8=899[:!%>>"<[ME/;
ML<]AQW9J.W9.SLE"W$-P=_S<.ST *>O\1!%]^,4UH<G,# 4J!7NYT0.;TW<H
M.)WR)-J\/AAL&@W&.8Z9 RVVCNF-LHLX(<Y4SE^($REA)^H$*0M4LA/S^RE/
M'U4\K'LX#QI#+H=,N5.42_?NG266)HJO-W0F;A92;]2Y@7._?8B]//CO-VTX
M=%\.X<8V.F8(/ADY\Q^!>O[!&0V'8'YYV"3H+$>)*O]X.(3V4M#YDJ$ !> 2
MCWH-OHNQ"98ZN@^F5,D_O*DS;U!%ZAK<MDQZC3?^![,)DE$/GX_*?MWVH=FF
M\=X)K;/0TXO;?GOS*KSY]'G\H7(2;[R3E%1??UNZ1L]*U^B-S<M ]S[]EO[F
M_!&GP?#".:!0VJ]@_/MO>]4K?)?.M9MOJV?\+C]>Z]PZ<7?9H(_9.0_9Q7Q1
MEZ=Q2H>DFV51^?6N U.1<@D=--^V=P]G/_)3#)1_N+DGMS0@_WK\%=]N.[OH
M!_N<Q)Y_[8U9D$_IY5_!L(XP>O>]ZS1;:VO-U4ZGL\D:S!1G^]&BZK[B<>VV
M\_:3^&^$W"1&GB-R^FH7H $UX72)E0FB6U3,%Z5^:6W^:5__/\>[W\&ZWV%/
MPE'WZZYMM3O[NU].G<_[W8-_/'%/3O:^'G1/?QSO<B^^H+/BQ_'VM^X)].W+
MX?[^X<^3_YU)'</YMZ3G_X5WLO77:EO_.6S]M=K6GY-S<I,4>FK!GPM76_*>
MH)_6NKAO,.NTRKR\=(O.[)SL;O\XWB-?L6K:Z7X]WMW]#K?-; 3[/'E*&$!&
MG!H2G'Y6-XFCO23+2\_M)IE+9\F]#?6UYJT&YX''U9@TINYFP_WF*^^C<Y/Y
MNU&PG1_B@[BW\3V%%F_Q\>Q].M'\)3"1W7S#G\B&'Q<G^!8'Q ,F^05.K-J9
M51,Z]4WZ N>/G!?U!#Y\ G>)G4DY<.N)?/!$EGW@J#[<\<:Y>X>U"^;%.&"D
M97L&=PRF.[N<M5'7YUW89RHS(EY+K1)[N2/K:3L]FZDQ:Y(Y7)+L@_.W_U?\
MWPL9+*&L/C@O='B[8*D<4.W.IQSB(OBNGL<9MEX[PY[#&;8^Q\ZPU^;X>NK7
M$V[R!&O2(FRXTVB].U]Y8@R@T?:V-PPS^/@_'B.MI]@FO5\MD?'>^7"=W*;
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MMWMF%_6#^OR<2;Q3WT9/80]M-=UFLWEO[?UUN]:G,('SZV6?2KQT3F^3/^)
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MXWAT%L:N\^>1<T*@E^\+=9%LM#$B-V_W2*O16D#+9*M5WR/3OD?>KX%B?7_
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M;Y\/=_Y)GKYOI]_W/_U_4$L#!!0    ( $8_U%;@F/@6^5<  (I/ @ /
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MN0E"= !\A&R8F6^L\>B<3-26'&A+2L^B7":?TV6SC/)F.44%I"^WS4ES9#W
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MG9 @X9N?9V;T\12F6+1N-R]-:Y.[;W[=^1A59Q4^MH7N)7@+3;BBU*LW\2@
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MP VTK^4U=Z,:=?)9?[XS*1A^"#>BOTS<290O)YTWB>V(XE#E2<I1AQ4&*NU
M.BW==8G\US5)9,3Q^5>S$;@MY</-R\+4MV2&417.)5,4."6L'&H$? 8HL51E
MR"/%L0/T-Y%$<,GJ\<SW(5LUNR!]0YBTT/5/90:5:M4Q[#N 4H+6;=W4[5G
M9^*656O8'@S[7Y>D*=:@7%,9$B18IHZ0\3S6DDJDS0!YG;'8Q9Y5>:'C8:S3
MN\6A]%-(0%$)NX2W*AAPD[6\Z\?GTU7&0E8H" = !13J@[LNTUX-UX+J\-"'
MT'/V=O=CP'7R"<]+FN.&Y_1K+P1J^/EMXB\T 89 94+<>'7.D=I-N O9FUJU
M0W"4_EU7C+D]MIA&?&:%=)(UTDS-34DH"QRC*8AM4DL+">< M9P\_P$XUSF
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M8BJB?N!%H=G RIEI1=]L:O&\N%S"2,#G</.PBJJ.H']M@)LP0/CX-4L</,@
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MGJ]B5U'NSY1P2DG3 &PIY3.GN)H_DG\U<-@HZDT,LPE32OO K_&(NTTSV_9
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M'DT)A5@09Q')92"I1*._BM!CZ\5VL-(*=#\U1:1HTAAM;RNF+:"I 98&*MI
M!6:*^G^K?BM'=X;HVB9PZ7[OOK5KE#JH1#]Q"E' X9AQ$OQS#QZN_'G&TZDH
M!\PI4AT3Y_6I.V6M'O3$<F+B*%;Y2FQ0!#D97$ &*+F8R9'NY7B<L\EHEA0
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M,R$JPV98HO++QRD&#1=+B0;Z$:U;BNN9%K^[]2OFJ*GE](R&56B'5_S'*6]
MV(HGJNQ5UM2]$\;I+9Q1+K;N5G%.#</H:3VP8.8 61*Q\-M9;L-,>& Q5L6Q
M"9/U>U<EK/1B[^F6VO:(SZ,-HMU:H*)Y4$1<CB',@&632HIX GSPO6;$R842
M%=H?A,XXEQ=1PF"&' &FU+E*2$,(8_8;V3/ 1(U1*B*!C@;2QH,&<L[]K;#[
MG(_/U;<N6IXYT8).SO'Y-0D6,<=/.<P7 WA4%8G2%'<&IDUT-A&2B>"FT8AU
M%%;W$[&1L52K+H\AH-0NO,Y4[?S68-C <31C1*C,/)AJ8IK_/=S[QFY'S8!
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M$V&IU,X+EE8'L XC4!9SMHY%?8Y==H"P'5+=_Y(.T._YFK"JN4_02D .J9Q
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MB'V[CY;Q@"Q5NCZ4\T  -_SR$V W\(PQ!D\[L!\N@="8FX9S1Q"D::RCP/+
M69DX8)'VN48^.E68'P_L(<J6!4?2J)-<9/W*LPR4SA0I"JN*9\R^<V[ (HGS
M6.$QH(XTK1P&!#5%\4@&>/WH'NB5@Y'61I=*/FH]8315FC%%YL$R*SCF@K4[
MK8-PF4EIL#B%)LV6-A&M(7T.+#SC])<RE?IQ;!J:@T+!A"IEE/+#U/,2 [Y*
M712%8Z8ZHFX9>-Q"BD+8V5<U,/P%3FJBN)V_R66TP]:_@(U@[NR$_5?@W#YF
M(YAK[:<?JY1_W2ET:&-8<<V]A-ID==4"MVHT<__=N4;>54M(/Z6K4W^S26JB
M+3>UZH'OK*[W_6T&8DS]^PCR)9!FK*9^L,>* &^&TFO7NWIID))FF*'RBP23
M;<-?%>=$+@BBJOPL]5(U*[<Z7<BLJD1;RP7QVY0633RD'!U78=E5FXM].]YK
M[_,1OW<'?SUW'[]4NW4WC-OX<R_@*A<+&P%@ ,%A/</MV#F_7[M/$9Q@65U1
MT4BG@Y!:=&':#^(\S<^I(RYN7@_H(]?6..,CQ$8)L)V*@+(ER38N$R $R6!#
MCL289'.?OO<"LI4T D8"(,60,<7 I!VVGY&PEEV*(8%[(W=5((JS[3 $C/*+
MENK*\R_X:R6<VU$ I%S2W&!-4E(&FM2:LQ.:IU>>T(5%W?<&"J\7>ZW.&X4^
M"K]A,+)EDOC EK*[F2@-)%]0\I64Q!&F<6U\->/CQ3HOK/M/%]9]<_'3^.K\
M]/Q-OW<V^G=K:H0MEV7%D^Y_8 .*DA2P;@?SC?N="ZEE(?Z"!_LYR]_[UD>1
M59+2(,I)+%>Z;'$,%9L5@>C+=5*51=.L Y<5@\VP<JXCH&].I5-8P3:DH,08
M8%[+A#\.4CLE8KDD.RC#IB=Q8VD-S5D;G46V-LG&'M:KX%Y;R:$D?OT'<9@D
M-,=[I=4 Z6Q<M.*4-/H^B@3%;3M[>![G?M,P^=9,)BU97$\9.9-A*B%?+JU#
M@38X):B\ZQ$])+4H-LL2.WUS+Y/NG'&B>2]/GKX^Q$TZZOS=LG>T+R63@C;5
M6*DUQRX07C2AE.E"]#9FHF5>;,"U+ _<V-=B QR3ZH^5W5)>8T<//!Q-N<2B
M^B01-T^0:*W(^WK@WY/Q$BOES[5P3AH@IDZF-K[OU=%09\P<U7/,696V?J+5
M@]ECI00^XT5J=@H:/>AD-RJ..%F[@-L>HS?4SSBR.XISL$ZRD.NI\1:,Y-.H
MQ'9+D;K_T"I"@N+D/K3/)YJ;).2W5;=#+KHO8VSMV%JJ/EE9 %+F,4R\%&8,
M*][&*B!&0SCJ $V-A)P7BE++Y4_;[G,T?$YQO4H,DHIL2+WF5G$L%@QSB'8<
M:W[Y2IH(,$R<>B[]&KE%+*O[KMZN X"\MOL^%(G N20LUW-+6NJBJ.69!?&=
M9%$[0N;/X=G%ZAF#%1/@!$5*3V:VUN\QS.RII&2!6IBU7!RU7K5FRVICOU"O
MG!#M8,5Z7VM+"\R$]A;Q\@2D!YS3./R^&$)*<-U%!E*I4FP;K?_"S!1=56-.
MRZWW%\7M<,\(2^_X/2'ODV2=C4R^:.7A\2WRD'CT\Z_QZ,\0CW[^-1[]Q5#3
M@S\]MN<5TMV<7HVQ)N!J3.4!NV]/KQ'M1^?CBW?7K6:&7DRRB'*#YUKT?,][
MQDH0)@G;BB7?I=6F&YL2%1I0]0SG]+*^7ED9ZU.:P5KDU>:<<N*<2[(6 ]X)
MP/:*/-=\2>P85%<IM0^%1IGZ.>,BL44;'+"$L>\K*700ZU_\NK8P7G8@,[#0
M<UIE+5_:CA7G<UU<>SUW[JF0W6@Z+;!X(ZK7.+CP.=I+G$)JFYV16QZ;%8 =
MR6"K3'N)_\$0USZJ+8_,=V"3GW>#SW30O'_G/_43%&I*F%>Y6W-@M'A.UBV#
M^SY/V6+;8%M85#4D4>*..DEB:RMR[ %"(*X;\>/8-'5R_G#HR7U&SO=\4)$_
M7D"J'<RX\66-P.PKH AJVZL)ST[3^\M['JCJEG1E:WB0J"+!GO8V0.6;;0>A
M0-2B2=NFN[;TG%)796J%!<M4V_;V,JS5K0:NM@A?X- /4:+="^QSJD(#RG0B
M.:Y>O%0%PV5$S3B WNF;2D*);C+GGZ<J$7B!Z1G/:ZUYK][1MKDFF(@%"2.P
M 2<2--5\R.=4Z\O@GBT:;%=J*IV=R)%#:C9N8*C0DQL$VK/!&G28:DX4=L$=
M?94.3QO/J+&G-4;^/M5K3Y]Z14(WI\?C:REJ&$E01-RL9">Z>#D:1V4JA3?&
M)@J@#>N[LC/?W&JTB&]V@>!0D.5VCOXHWT/L/G9_5E=-R5B"[BI/8OSP R 9
M?K$ G[E:<0^O!PXW;'//QED0UXR7J8[,/['F,^"[=4G;A>L(10:8PH]26@>#
M*Y3^[N6SO6 Y7 R#+>=..::V!7"CV_QE:!>8C!0PA:T)GR.%"ZS]"=#=?;SM
MPQ_RH2>CRF'<#G,96RM5VRFE0:C"UHX^  : = THA P%D-!Y5)_<*_'P0;%@
M\YJAH+F\E?([8B0^F]G!C42R64KI0BK.R6D6T\<>R5]![OLM8#CLD*2";-LU
MUIK@S,NHK6NVD.ZI O/8HP-&?4)?Z2HCH)Y24HV[*"N%:[3ER*/V><F.2^*[
M^:(-[P<S+OLQI-<7YS=V!_0.?W(1Q-9+N#O\J*<RFEZ]9"(>R2<(2?'!25[M
MXAP;RG/;=!<)6(I/I/VSC(-&)TQISL2?@VW6''8T07*NG#QCU;@M.KC^C?#Z
MN]6'#FP2A;'583&J>W=Z8N+"11GXDT3V&RJB(:(&S/%.V\"?4TKTG5FJI>U[
M_@M0$9"7H:(%4H)"^C X-[?,[E+K>?I2D)0MX;T62YB>M2W]OZ].#UGW1M/!
M?3$V-D2EF(=L)'TFE5),XD?HC0@FB4K? VQ.#__OHP+HD_3S_ @3/L2+]>*K
M%^LS>+%>?/5B_8=0R7^:U+[$KRB[I(-*I'I-'<,LE^\?@(YCK))3>BXJU+E0
MW;'F 2@ZI;0Z:2^K8\^9%/%25&T]'^G3@KQB'3ZK:+*2/[R1&B?IY#A/"(\W
M\Y4G%M>!]#PJ= ^#XPO<^OF_GNP#]?B*UQH#^PG=/D5>PHVNL%?60)2LBJS_
MT'8:K./%7IVU=8Y[V+#GC7%_?']_%5ROC@[Y>U&[H[.ST]'Y\3AX<W9Q-#H+
M+D=7-^?CJVO^6OM?@6'K'N]]^*'6V7S^H]7+P+Y6G7'MONZ5SIN!?'JX:W9!
MRP<J,L&/P^"'> 8D;%#;^AB@W;P;DI^MI[WG15ZKY12?^@0WV)_E3QWAK4K5
MC*PD*?-JW[P(_H\A8[\D7MQD:OL/Y&K??^,F^0"*][O#D>>V8(_%2S:?+S_<
M,B_^N1>\55&,S6Q&MSHMP8C>_[Z8\WE?)QGBR@=<KR7+"2YO?_^#+C(J"OBE
MA6(_X!IC]'N]%+1X=PB*#JWQ/V!:TI=M9\,P6UBLX4O[:-3V^110@#5EETE%
MX(BS_C%]#T-4'WMMYX8$/=<4+AV2VCM_XHXP7Q1_>ZB>)"?O</ =H8,OY #P
MQ1+6,RY5G[SBIVDX;&I1'TCE^3!JYT.UW3\AW>_7OCZ^WO4C6&++>7 ^#%X#
MF]6KIMKUH=3/CZIVK1_B4Q_@SVM=Z/_F/DS(&X_'%W]@\X]!.*QY)_9M4&%=
MLT$9^;%8]N;M;&1B^"WN\%-_ZHGWQ4I,$_\'@<,J#L,36GV&[>WO!V,%0O<(
MO]E\IU:?91-O5!ZEV"?\K3)&A?,2/_YE@KVGSY_O[3Q[]NS[+\3']R>#'M<N
M'$D.4E"[&DW9PE7-^?8H@AQ?%^Y>^"'1FN\.B-%EJ7D9G"$%?PW>?/K@S7>?
M-'CS21."'T02NT<7)S^C=K/[P\W;L\/_!U!+ P04    " !&/]16_B-@_;\.
M  "^-@  #P   '!O8VE?97@Y.3 Q+FAT;>U;6W/;-A9^]XS_ ]:S[;8SDBS;
M2>M;,BM?FGC'L5U+V4Z>=B 2DI"0! .0LI5?O]\Y "52<MQD&SO=3//@6! (
MG.MW;O3AR\&K\^?K:X<O3WLG^%_0O\/!V>#\]/GAIO\?WVZ&KP^/+D_>B/[@
MS?GILXV1R8I]L=7-"S'0J7+B0MV(:Y/*K.476J*OK!YMX$$\>E4]5ZC;HBT3
M/<[VA=7C27$@4FG'&A^[&\\/CYZ?WD[T4!=B;Z^S=;AY!$*NEHZH[?\^&[K\
M8'7+IU)7NQQ;NP>B3M[;TA5Z--M8D##H'9V?BN/3\_.KWLG)V<6+9QO=#?[<
MO^H=5Y\_FX:AL;&R[<@DB<R=VA?5;P?B1L?%A$[I?D>2/!Q<5\=/E2UT)).*
MVL+D3?(3-2HV6*N'@Y/JJ7#>4SKN\.S5"]&_/GZVH5,Y5O_I=K<Z;_/QANB=
M#YYMS/F8*%(3:-#9@IZ=W;P@P0Q.[KLAJ&=9+=N_+Y*/FDD;?+*VY@M#4Q0F
MY;6-YU?7I\=G_;/+"W%Y-3@[[HOCR^NKR^O> $M_Q$S^5WJVM\5IKS\01]>7
MO9/?>F^^!@TO>M<G%Z?7+?&JU^_WCE^^[I\.!GW1W7KRI-O>V=G9_1I$#52B
M\HG)E-C[>5=LBI]VNNVMW6[W:]$RDK=U2I[L_BR:X,)$D;WCQS7#(J/!HV$3
M_]SJ;#\E-[R#4U[26:SH]!V=,9A>71Z+[9UVM[NS]YE8.F?YC]+]NX+X!#2X
M!Z0C\*NL9]:J2#MM,G&9 QJ=Z&69*;,()_]]N_-T6[S224)?7UD]E85:7[M*
M9*12G"#,2!R;-,67_<)$[\3=TGHH$7RA.+5P=.GPY+]*>-?6TY;8[F[OB,VK
M:QSN;K15FZ+=%G-IK:\%<1T;FQLK"ZRUQ%D6=<0/%[W^2>_7?0$[.OM1_%!,
ME/@^B=^7Y@#2RF4V^][RIQ];0B+@R%AG8Q$K![J4%3*+07=6CF14E!8+D+*,
MIQ(JB87).7P)G;G"EJ0$M[XV,E;0):F*^4LZ(58CE3F%C3$8M9J$4IA8SO"M
MUV^,9V0AD#1,I!-L$%C366'H89WI0D^5D&.K6-D.4:R8\,6Z*(G=<).,(CRH
M"Q6OK^ELJEQAK!,537EI(YRO>*N3B2)VGFQW6]UN5[B)M% ?5FCK7#B.A.,0
MS]FT')L6SG&EA,V!/"ER;XLBKTRQ)7!0F10D20WEC*UQ#MM,I%3,-\@<GVX1
MLPN5S()II\&TAPKD*K =EQ$?,3\7_--/(D4[TKMC1@SHM0*L\GGX/!K!X/"@
MNLU)[*XC!A.X2I081\N!P_DV[7AG1,^"(1-%)?2<"0A-#DU9>"N$E-@*6\*5
MP[?837OI' =S<V0?1#S.CJ!BF+^=B>K"R&10"=$;*+E;I=A62)U!HE;ED" 6
MV9+%R)JTKI3J9@4.B ZR')*!@O'@R*%2F<B,(&E83881(]-R)-*I2DR^,*#U
M-5R3UWBI+@#9D>*5F#0+KD8Z";+3>#@UK@"5A%Q$K+$%">P78U,@0?O7SD/#
MQ.. 4:_SHG/5V>S!+LGAQ8O$#"'.*VD+8(,CPY'>1.&S!2G6F42MV.O<^Y;]
MY)'$]#C"&E0NU0 7XIO<>6Q(3$[!M6#W"C@)X0T5+:8R)F2$V1=69BXX4F:
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M\U"PO@9=.X4-Y+P$"3K2(14@V85M9!'#DH7EZH[7PKDVW."S@J%BQ=;,NO%
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MC>MKC8BXU%=EQ80AE(PF9!RQ;]KXUL7\M.67 :J2NR7&?B3*E?R,0HD.CJ9
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M,#(S,#8Q-5]L86(N>&UL4$L! A0#%     @ 1C_45L',8S=2!P  S5<  !4
M             ( !APX  '!O8VDM,C R,S V,35?<')E+GAM;%!+ 0(4 Q0
M   ( $8_U%8!.'HR;Q4  #YS   +              "  0P6  !P;V-I7SAK
M+FAT;5!+ 0(4 Q0    ( $8_U%8_S2UW[:L  /V !  /              "
M :0K  !P;V-I7V5X,3 P,2YH=&U02P$"% ,4    " !&/]16X)CX%OE7  "*
M3P( #P              @ &^UP  <&]C:5]E>#$P,#(N:'1M4$L! A0#%
M  @ 1C_45J3JEM_1(P  ;:@   \              ( !Y"\! '!O8VE?97@Q
M,# S+FAT;5!+ 0(4 Q0    ( $8_U%;^(V#]OPX  +XV   /
M  "  >)3 0!P;V-I7V5X.3DP,2YH=&U02P4&      @ " #R 0  SF(!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
